{"study_id": 22634, "supplement_id": 1272, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of Lacticaseibacillus paracasei LPC100 on bone mineral density loss and related markers in postmenopausal women.", "results_summary": "The probiotic group showed no significant bone demineralization compared to the placebo group, with a notable reduction in gastrointestinal symptoms and maintained vitamin D levels. No significant differences were found in other secondary outcomes.", "population_specificity": "Postmenopausal women", "effective_dosage": "Not specified", "study_duration": "Twelve months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:57.313961+00:00"}
{"study_id": 22637, "supplement_id": 1272, "safety_score": "30", "efficacy_score": null, "quality_score": 60, "study_goal": "The researchers aimed to report a case of Lacticaseibacillus paracasei bacteremia in an infant following probiotic administration, highlighting potential risks in vulnerable populations.", "results_summary": "The study found that L. paracasei from probiotics caused persistent bacteremia in an infant, requiring antimicrobial therapy. Genetic analysis confirmed the blood isolate matched the probiotic strain, suggesting a direct link.", "population_specificity": "8-month-old girl with hypoganglionosis post-jejunostomy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:58.857286+00:00"}
{"study_id": 22636, "supplement_id": 1272, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to assess the effects of Lacticaseibacillus paracasei 207-27 on sleep quality, safety, and potential mechanisms via the gut-brain axis in healthy adults under mild stress.", "results_summary": "Both low and high doses of L. paracasei 207-27 improved sleep duration measured by wearable devices, modulated gut microbiota (increased Bacteroidota, decreased F/B ratio), increased short-chain fatty acids, and reduced cortisol levels. However, PSQI global scores improved across all groups without significant differences between them.", "population_specificity": "Healthy adults aged 18-35 years under mild stress.", "effective_dosage": "Low and high doses (specific amounts not detailed in abstract).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:59.601833+00:00"}
{"study_id": 22635, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Lacticaseibacillus paracasei GOLDGUT-Lpc969 in preventing allergic rhinitis by modulating the Th2 immune response and identifying potential functional genes involved.", "results_summary": "L. paracasei GOLDGUT-Lpc969 significantly reduced histamine release and degranulation in vitro and decreased disease indicators (DAI score, serum IgE, histamine) and Th2-related cytokines (IL-4, IL-5, IL-6, IL-13, TNF-\u03b1) in OVA-induced AR mice. The gene K03671 was identified as potentially key in alleviating AR symptoms.", "population_specificity": "OVA-induced allergic rhinitis mice and LPS-induced RBL-2H3 cells (in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:00.006294+00:00"}
{"study_id": 22639, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of LCPS-1, a cell wall polysaccharide, in the viability, survivability, and stress tolerance of Lacticaseibacillus paracasei strain Shirota (LcS).", "results_summary": "The study found that LCPS-1 significantly enhances LcS growth in bovine and soy milk and improves tolerance to acid and bile stress, with the mutant strain lacking LCPS-1 showing reduced survival rates under these conditions.", "population_specificity": "Not specified (in vitro study on bacterial strains).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:00.234740+00:00"}
{"study_id": 22641, "supplement_id": 1272, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of Lacticaseibacillus paracasei CIRM BIA 1542 (Lp1542) on teat skin microbiota and mammary gland physiology in dairy cows as an alternative to antibiotic treatments for mastitis prevention.", "results_summary": "Lp1542 treatment increased lactic acid bacteria and total microbial populations on teat skin and in foremilk, altered microbiota composition (higher Actinobacteriota, lower Pseudomonadota), and did not trigger major inflammatory responses or affect mammary epithelium functionality or integrity.", "population_specificity": "20 Holstein cows in mid lactation.", "effective_dosage": "Post-milking application twice a day.", "study_duration": "15 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:01.414092+00:00"}
{"study_id": 22638, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and validate a precise method (PMA-qPCR) for quantifying viable Lacticaseibacillus paracasei in probiotic formulations to ensure accurate quality assurance.", "results_summary": "The study successfully developed a highly accurate PMA-qPCR method for quantifying viable L. paracasei, demonstrating strong linearity, high amplification efficiency, and minimal bias between theoretical and measured values. The method was validated across various sample matrices, enhancing probiotic product quality control.", "population_specificity": "Not specified (focused on in vitro validation using bacterial strains).", "effective_dosage": "Not applicable (method validation study).", "study_duration": "Not applicable (method validation study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:01.551856+00:00"}
{"study_id": 22642, "supplement_id": 1272, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the UA-degrading capability and probiotic potential of Lacticaseibacillus paracasei JS-3 isolated from \"Jiangshui\" for managing hyperuricemia.", "results_summary": "Lacticaseibacillus paracasei JS-3 significantly reduced serum and fecal UA levels, restored gut microbiota, increased SCFA production, and improved renal damage in hyperuricemic quails. It also modulated purine, tryptophan, and bile acid metabolism.", "population_specificity": "Hyperuricemic quails induced by a high-purine diet.", "effective_dosage": "2 \u00d7 10^8 cfu/d per quail.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:05.577905+00:00"}
{"study_id": 22643, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the sex-dependent effects of Lacticaseibacillus paracasei BL23 and milk on intestinal and behavioral responses in a mouse model of colitis.", "results_summary": "The study found sex-dependent differences in colitis severity, with female mice showing more severe symptoms. BL23 in PBS improved weight recovery in females, while milk was more effective in males. BL23-milk improved colonic ion transport in males, and both BL23 and milk influenced proinflammatory and anti-inflammatory gene expression.", "population_specificity": "DSS-treated male and female mice (animal model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:08.108566+00:00"}
{"study_id": 22644, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether inanimate Lacticaseibacillus paracasei (CECT9610) could attenuate store-operated Ca2+ entry (SOCE) and impair migration in colorectal adenocarcinoma cell lines.", "results_summary": "The study found that Lacticaseibacillus paracasei downregulated Orai1 and STIM1, attenuating SOCE in colorectal cancer cells (HT-29 and Caco-2) without affecting normal colon mucosa cells. It also impaired in vitro migration, likely by reducing focal adhesion kinase (FAK) tyrosine phosphorylation.", "population_specificity": "Colorectal adenocarcinoma cell lines (HT-29 and Caco-2) and normal colon mucosa cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:08.914939+00:00"}
{"study_id": 22647, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how Lacticaseibacillus paracasei extracellular vesicles (LpEVs) inhibit colon cancer cell growth by affecting tumor metabolism, particularly glycolysis.", "results_summary": "LpEVs entered colon cancer cells, inhibited their growth, and reduced glycolysis-related markers (lactate production, glucose uptake, lactate dehydrogenase activity) by decreasing HIF-1\u03b1, GLUT1, and LDHA expression.", "population_specificity": "HCT116 colon cancer cells (in vitro and in vivo models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:09.033752+00:00"}
{"study_id": 22646, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the synbiotic combination of Lacticaseibacillus paracasei K56 and prebiotics (particularly GOS) for its potential to regulate gut microbiota and mitigate obesity-related markers.", "results_summary": "The study found that L. paracasei K56 combined with GOS significantly increased GOS degradation and SCFA content while reducing gas levels, alongside favorable shifts in gut microbiota (e.g., increased Bacteroidota and Bifidobacterium, decreased Firmicutes/Bacteroidota ratio).", "population_specificity": "Obese female volunteers (n=10)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:09.233253+00:00"}
{"study_id": 22645, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anticolitic effects and mechanisms of Lacticaseibacillus paracasei CCFM1222, focusing on its impact on intestinal barrier function, inflammation, and gut microbiota in colitis mice.", "results_summary": "L. paracasei CCFM1222 reduced disease activity and colon shortening in colitis mice, improved tight junction proteins, lowered inflammatory cytokines, enhanced antioxidant enzyme activity, and modulated gut microbiota by increasing beneficial bacteria and reducing harmful ones.", "population_specificity": "Colitis-induced mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:09.240065+00:00"}
{"study_id": 22648, "supplement_id": 1272, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to describe the clinical course and treatment challenges of catheter-related bloodstream infections (CRBSIs) caused by Lacticaseibacillus paracasei.", "results_summary": "The study reported recurrent L. paracasei CRBSI in a patient despite antibiotic and antimicrobial lock therapy, with resolution only after catheter removal. It highlights the rarity and uncertainty in managing such infections.", "population_specificity": "A 46-year-old male patient with recurrent CRBSI.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:09.727682+00:00"}
{"study_id": 22640, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of dietary Lacticaseibacillus paracasei NSMJ15 on growth performance, immune response, gut microbiota, and short-chain fatty acid profiles in broiler chickens.", "results_summary": "L. paracasei NSMJ15 did not affect growth performance or antioxidant enzyme activity but increased CD4+ T cells and decreased acetate concentration in cecal digesta, while altering specific microbial genera.", "population_specificity": "1-day-old Ross 308 male broiler chickens", "effective_dosage": "1 g/kg of diet", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:13.093165+00:00"}
{"study_id": 22649, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Lacticaseibacillus paracasei strain Shirota (LcS) could improve daytime performance in healthy office workers with sleep complaints by modulating psychological homeostasis via the gut-brain axis.", "results_summary": "The study found that LcS intake improved afternoon attention scores and reduced theta power on EEG, with associated changes in heart rate and sympathetic nerve activity, suggesting potential efficacy for enhancing daytime performance.", "population_specificity": "12 healthy office workers with sleep complaints", "effective_dosage": "1 \u00d7 10^11 colony-forming units daily", "study_duration": "4 weeks per intervention (LcS and placebo)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:13.691623+00:00"}
{"study_id": 22653, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 85, "study_goal": "The researchers aimed to study the effects of Lacticaseibacillus paracasei 8700:2 on the single-cell parasitome, particularly Blastocystis, in children with celiac disease autoimmunity.", "results_summary": "The study found that L. paracasei supplementation did not significantly affect the prevalence or quantity of single-cell protists like Blastocystis or Dientamoeba fragilis. However, protist presence was associated with increased bacteriome diversity and inversely correlated with certain beneficial bacteria.", "population_specificity": "Swedish children with celiac disease autoimmunity (n=78).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:17.257495+00:00"}
{"study_id": 22650, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of Lacticaseibacillus paracasei supplementation on intestinal stem cell proliferation, immunity, and ileal microbiota in broiler chickens challenged by coccidia and Clostridium perfringens.", "results_summary": "Lacticaseibacillus paracasei decreased JAK2 mRNA expression in the cecal tonsil on day 13 and helped reverse coccidial infection-induced changes in ileal microbiota, increasing Lactobacillus richness by day 19.", "population_specificity": "One-day-old Ross 308 broiler chickens", "effective_dosage": "1.0 \u00d7 10^9 CFU/kg", "study_duration": "Supplementation from day 1 to day 19, with challenges occurring on days 9 and 13-18", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:17.396600+00:00"}
{"study_id": 22654, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether probiotic fermented milk containing Lacticaseibacillus paracasei JY062 could alleviate constipation symptoms in mice by improving gastrointestinal motility, gut microbiota distribution, and functional metabolites.", "results_summary": "The study found that FMMIX significantly improved GI motility, increased beneficial gut bacteria, elevated short-chain fatty acids, and upregulated functional metabolites, leading to constipation relief in mice. It also enhanced the expression of proteins related to intestinal motility and modulated serum GI regulatory peptides.", "population_specificity": "Kunming mice with loperamide-induced constipation", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:17.599501+00:00"}
{"study_id": 22652, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Lacticaseibacillus paracasei BEPC22 in combination with Lactiplantibacillus plantarum BELP53 on adiposity, microbiota, and metabolome in high-fat diet-fed mice.", "results_summary": "The combination of BEPC22 and BELP53 reduced body weight gain, food efficiency ratio, white adipose tissue volume, and adipocyte size, while altering gene expression related to fat metabolism and improving microbiota and metabolome profiles. The treatment also reduced plasma leptin levels and promoted anti-obesity microbes and metabolites.", "population_specificity": "High-fat diet-fed mice", "effective_dosage": "Not specified", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:17.832354+00:00"}
{"study_id": 22655, "supplement_id": 1272, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of Lacticaseibacillus paracasei AO356 on gut microbiota and assess its safety for use as a probiotic.", "results_summary": "L. paracasei AO356 significantly altered gut microbiota composition, increased the relative abundance of beneficial bacteria (Lactobacillus, Bacteroides, Oscillospira), and suppressed weight gain and fat mass in mice. Safety assessments confirmed no significant adverse effects.", "population_specificity": "Mice fed a high-fat diet.", "effective_dosage": "10^7 CFU/mg per day, 5 days a week.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:18.985890+00:00"}
{"study_id": 22651, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of capsular polysaccharide (B-CPS) and surface layer protein (B-SLP) from Lacticaseibacillus paracasei S-NB on intestinal epithelial barrier dysfunction and their potential as postbiotics to modulate gut microbiota.", "results_summary": "B-CPS and B-SLP demonstrated protective effects on intestinal epithelial barrier dysfunction in an LPS-induced Caco-2 cell model and modulated gut microbiota by increasing beneficial bacteria (e.g., Bacteroides, Bifidobacterium) and decreasing pathogenic bacteria (e.g., Escherichia-Shigella, Fusobacterium). Total short-chain fatty acid production also significantly increased after fermentation with B-CPS alone or in combination with B-SLP.", "population_specificity": "In vitro study using Caco-2 cells and fecal cultures.", "effective_dosage": "100 \u03bcg/mL for both B-CPS and B-SLP.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:19.598083+00:00"}
{"study_id": 22656, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the radical scavenging and anti-wrinkle effects of soymilk fractions produced using Lacticaseibacillus paracasei MK1 fermentation.", "results_summary": "The study found that a 5 kDa ultrafiltration fraction fermented with Lacticaseibacillus paracasei MK1 exhibited the highest radical scavenging activity and potent anti-wrinkle effects, including increased type 1 procollagen production and reduced tumor necrosis factor-\u03b1 production in UVB-treated human dermal fibroblasts and HaCaT keratinocytes.", "population_specificity": "Human dermal fibroblasts and HaCaT keratinocytes (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:21.032082+00:00"}
{"study_id": 22657, "supplement_id": 1272, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Lacticaseibacillus paracasei supplementation could improve endothelial function and cardiometabolic health in individuals with metabolic syndrome (MetS).", "results_summary": "L. paracasei supplementation significantly reduced remnant cholesterol, which was associated with improved endothelial function. In compliant subjects, it also lowered triglycerides, alleviated MetS severity, and delayed weight gain, but showed no effect on insulin sensitivity or pancreatic beta-cell function.", "population_specificity": "130 participants with metabolic syndrome (mean age 45.97 years, 73.1% male).", "effective_dosage": "10 billion CFU twice daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:21.549371+00:00"}
{"study_id": 22659, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether oral administration of Lacticaseibacillus paracasei K71 could protect against UVB-induced skin barrier dysfunction in mice.", "results_summary": "K71 suppressed UVB-induced skin damage by improving water content, reducing transepidermal water loss, and decreasing epidermal thickness. It also reduced inflammatory cytokines, increased anti-inflammatory IL-10 production, and its RNAs were found to enhance IL-10 in macrophages.", "population_specificity": "UVB-irradiated mice", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:24.857378+00:00"}
{"study_id": 22658, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine the impact of Lacticaseibacillus paracasei 8700:2 supplementation on the faecal metabolome in genetically predisposed children with coeliac disease autoimmunity.", "results_summary": "The study found that Lacticaseibacillus paracasei supplementation led to increased stool concentrations of 4-hydroxyphenylacetate and decreased concentrations of several amino acids and metabolites, suggesting an influence on proteolytic processes in the gut.", "population_specificity": "Genetically predisposed children with tissue transglutaminase autoantibodies (coeliac disease autoimmunity).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:25.713885+00:00"}
{"study_id": 22660, "supplement_id": 1272, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of Lacticaseibacillus paracasei strain Shirota (LcS) supplementation on clinical responses, gut microbiota, and fecal metabolites in Parkinson's disease (PD) patients.", "results_summary": "LcS supplementation significantly alleviated constipation-related and non-motor symptoms in PD patients but did not induce major changes in gut microbiota or fecal metabolites. The probiotic increased the abundance of Lacticaseibacillus and altered L-tyrosine concentrations in feces and plasma.", "population_specificity": "Parkinson's disease patients (n = 128).", "effective_dosage": "1 \u00d7 10^10 living LcS cells daily (via LcS-fermented milk).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:26.230801+00:00"}
{"study_id": 22661, "supplement_id": 1272, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to identify and evaluate an antimicrobial peptide (Y2Fr) derived from Lacticaseibacillus paracasei fermentation broth for its potential to treat Vibrio parahaemolyticus infections in aquatic animals.", "results_summary": "The study identified peptide Y2Fr, which demonstrated strong antibacterial activity against V. parahaemolyticus (MIC 125 \u03bcg/mL, MBC 250 \u03bcg/mL) and was noncytotoxic, nonhemolytic, and stable under physiological conditions. Molecular docking revealed Y2Fr binds to bacterial membrane proteins and DNA polymerase, enhancing its antibacterial effects.", "population_specificity": "Large yellow croaker (Larimichthys crocea) and in vitro bacterial models.", "effective_dosage": "Minimum inhibitory concentration (MIC) of 125 \u03bcg/mL, minimum bactericidal concentration (MBC) of 250 \u03bcg/mL.", "study_duration": "Time-kill assay duration was 3 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:27.397727+00:00"}
{"study_id": 22662, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antagonistic effect of Lacticaseibacillus paracasei JLM against Brucella abortus strains during soft-ripened cheese production and assess its potential as a probiotic.", "results_summary": "Lc. paracasei JLM showed viability under simulated digestive conditions, inhibited B. abortus growth in antagonism tests, and maintained 86% activity of its cell-free supernatant after heat and enzymatic treatments. It also completely inhibited B. abortus growth in ripened cheese at 25\u00b0C by day 17 and showed greater inhibition at 4\u00b0C.", "population_specificity": "Not specified (in vitro and cheese model study)", "effective_dosage": "Not specified", "study_duration": "31 days (cheese ripening period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:28.266630+00:00"}
{"study_id": 22663, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of heat-killed Lacticaseibacillus paracasei (GMNL-653) on scalp health, including sebum secretion, dandruff, and hair growth, and its impact on scalp microbiota.", "results_summary": "Heat-killed GMNL-653 inhibited Malassezia furfur biofilm formation, upregulated hair follicle growth factors, and improved scalp conditions (reduced dandruff and sebum, increased hair growth) in a clinical trial. It also shifted scalp microbiota, increasing M. globosa and decreasing M. restricta and C. acnes.", "population_specificity": "22 volunteer participants with unspecified baseline scalp conditions.", "effective_dosage": "Not specified (contained in shampoo).", "study_duration": "5 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:29.042952+00:00"}
{"study_id": 22665, "supplement_id": 1272, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the efficacy of Lacticaseibacillus paracasei N1115 in enhancing gut development in Chinese infants and toddlers born by cesarean section.", "results_summary": "Lp N1115 maintained fecal pH levels, increased fecal sIgA content in infants aged 6-12 months, and enhanced Lactobacillus content. It also reduced salivary cortisol in the experimental group.", "population_specificity": "109 healthy Chinese infants and toddlers aged 6-24 months born by cesarean section (101 completed the study).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:29.586953+00:00"}
{"study_id": 22664, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the antiobesity effects of Lacticaseibacillus paracasei LM-141 (LPLM141) in high-fat diet-fed rats.", "results_summary": "LPLM141 significantly reduced body weight gain, liver and adipose tissue weight, improved serum lipid profiles, reduced inflammation, and ameliorated insulin resistance in HFD-fed rats. It also induced browning of white adipose tissue and activated brown adipose tissue.", "population_specificity": "Male Sprague-Dawley rats fed a high-fat diet.", "effective_dosage": "Low dosage (2 \u00d7 10^7 CFU/day per rat) and high dosage (2 \u00d7 10^9 CFU/day per rat).", "study_duration": "14 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:31.363397+00:00"}
{"study_id": 22666, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lacticaseibacillus paracasei SD1 (SD1) and Lacticaseibacillus rhamnosus SD11 (SD11) could regulate markers related to type 1 diabetes (T1D) and protect pancreatic \u03b2-cells in streptozotocin (STZ)-induced diabetic mice.", "results_summary": "Supplementation with SD1, SD11, or their mixture (SDM) for 8 weeks significantly improved glycemic control, insulin levels, lipid profiles, and preserved islet integrity while reducing inflammation and apoptosis markers in diabetic mice. SD11 showed the best results among the probiotic groups.", "population_specificity": "Streptozotocin (STZ)-induced diabetic BALB/c mice.", "effective_dosage": "Not specified in the abstract.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:34.006913+00:00"}
{"study_id": 22667, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of Lacticaseibacillus paracasei K56 on body fat and metabolic biomarkers in obese adults.", "results_summary": "The study found that Lacticaseibacillus paracasei K56 at 10^9 CFU/day significantly reduced body fat, visceral fat, and glycosylated hemoglobin, while higher and lower doses showed non-significant effects. Gut microbiota modulation was also observed in the effective dose group.", "population_specificity": "Adult individuals with obesity (BMI \u2265 30 kg/m\u00b2 or body fat >25% for men, >30% for women).", "effective_dosage": "2\u00d710^7, 2\u00d710^9, 2\u00d710^10, and 2\u00d710^11 CFU/day.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:34.646322+00:00"}
{"study_id": 22668, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Lacticaseibacillus paracasei JY062, alone and in combination with Lactobacillus gasseri JM1, on alleviating gastrointestinal motility disorders in mice.", "results_summary": "The probiotic combination improved GI motility by increasing excitatory regulators (motilin, gastrin, 5-HT) and decreasing inhibitory regulators (peptide YY, NO), while also enhancing beneficial gut bacteria and short-chain fatty acid levels. The combination also increased interstitial cells of Cajal and SCF/c-kit protein expression.", "population_specificity": "Mice induced with GI motility disorders using loperamide.", "effective_dosage": "5 \u00d7 10^9 CFU/mL", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:35.011434+00:00"}
{"study_id": 22669, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop strain-specific identification and enumeration methods for Lacticaseibacillus paracasei 8700:2 to confirm its efficacy in probiotic products.", "results_summary": "The study developed a highly sensitive and specific real-time PCR method for identifying and enumerating L. paracasei 8700:2, with a detection limit of 0.5 pg of DNA. The method was efficient, precise, and capable of counting viable but non-culturable cells, outperforming traditional plate count methods.", "population_specificity": "Not specified (methodological study, not clinical).", "effective_dosage": "Not applicable (method development study).", "study_duration": "Not applicable (method development study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:35.840164+00:00"}
{"study_id": 22671, "supplement_id": 1272, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to examine the probiotic properties, prebiotic activity, and anti-inflammatory effects of Lacticaseibacillus paracasei EPS DA-BACS, as well as its safety profile.", "results_summary": "The study found that L. paracasei EPS DA-BACS exhibited antimicrobial activity against pathogens, anti-inflammatory effects, and promoted the growth of beneficial gut bacteria. It also demonstrated gastrointestinal tolerance and no antibiotic resistance or virulence factors.", "population_specificity": "Not specified (isolated from healthy human feces, but no human trial details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:36.901711+00:00"}
{"study_id": 22672, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lacticaseibacillus paracasei NSMJ56 supplementation improves gut immunity and microbiome in early-age broiler chickens.", "results_summary": "NSMJ56 increased CD4+ T cells, decreased CD8+ T cells, reduced IL1b and IL10 gene expression, and enhanced gut microbiome diversity, enriching Massilimicrobiota, Anaerotignum, and Coprococcus genera.", "population_specificity": "Newly hatched Ross 308 broiler chickens", "effective_dosage": "Not specified", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:37.365157+00:00"}
{"study_id": 22673, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether long-term use of Lacticaseibacillus paracasei N1115 could alleviate obesity and metabolic disorders by altering gut microbiota in mice fed a high-fat diet.", "results_summary": "L. paracasei N1115 reduced visceral fat, liver weight, serum insulin and leptin levels, insulin resistance, and lipid dysmetabolism in mice. It also counteracted negative changes in gut microbiota and short-chain fatty acid levels induced by a high-fat diet.", "population_specificity": "Male mice fed a high-fat diet from weaning.", "effective_dosage": "Not specified", "study_duration": "15 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:39.374392+00:00"}
{"study_id": 22674, "supplement_id": 1272, "safety_score": "95", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety, tolerance, and potential gastrointestinal benefits of Lacticaseibacillus paracasei N1115 in caesarean-born children aged 6-24 months.", "results_summary": "The study found that L. paracasei N1115 increased stool frequency, reduced constipation incidence, and decreased abdominal pain, with no reported adverse events. No significant differences were observed in anthropometric parameters, neurocognitive development, or other lifestyle behaviors.", "population_specificity": "Caesarean-born children aged 6-24 months.", "effective_dosage": "2\u00d710^10 cfu/g, 2 g/day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:42.428244+00:00"}
{"study_id": 22676, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the immunomodulatory effects of heat-inactivated Lacticaseibacillus paracasei K47 on mice with ovalbumin-induced allergic asthma.", "results_summary": "K47 supplementation reduced serum levels of total IgE, OVA-specific IgE, and OVA-specific IgG1, ameliorated airway hyperresponsiveness, and suppressed inflammatory cell accumulation in bronchoalveolar lavage fluid. It also modulated cytokine profiles toward a Th1 response in both BALF and splenocytes.", "population_specificity": "OVA-sensitized/challenged BALB/c mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:43.829373+00:00"}
{"study_id": 22675, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the antiosteoporotic effects of heat-killed Lacticaseibacillus paracasei GMNL-653 in vitro and in ovariectomized mice, and identify genes potentially involved in this activity.", "results_summary": "The study found that GMNL-653 restored gut microbiota dysbiosis, maintained intestinal barrier integrity, reduced IL-17 and LPS levels, lowered RANKL mRNA, and enhanced TGF-\u03b2 and IL-10 in OVX mice. Whole-genome sequencing identified genes potentially linked to antiosteoporotic activity.", "population_specificity": "Ovariectomized (OVX) mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:43.980221+00:00"}
{"study_id": 22677, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop and validate a rapid, accurate method (PMA-qLAMP) for quantifying viable Lacticaseibacillus paracasei in fermented milk.", "results_summary": "The study demonstrated that PMA-qLAMP effectively detected viable L. paracasei with high specificity and accuracy, showing a linear relationship between Ct values and bacterial concentration (R\u00b2 = 0.9983). The method had a detection limit of 7.3 \u00d7 10\u00b2 CFU/mL and produced results comparable to traditional plate counts (P > 0.01).", "population_specificity": "Fermented milk samples (no human or animal subjects).", "effective_dosage": "Not specified (methodological study).", "study_duration": "Not specified (methodological study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:45.095931+00:00"}
{"study_id": 22678, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether extracellular vesicles derived from Lacticaseibacillus paracasei PC-H1 (LpEVs) could inhibit colorectal cancer cell growth and induce apoptosis via the PDK1/AKT/Bcl-2 signaling pathway.", "results_summary": "LpEVs inhibited proliferation, migration, and invasion of colorectal cancer cells while promoting apoptosis in vitro and in vivo. They also reduced tumor growth in nude mice and suppressed PDK1/AKT/Bcl-2 signaling.", "population_specificity": "Colorectal cancer cells (in vitro) and nude mice with CRC xenografts (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:45.184352+00:00"}
{"study_id": 22679, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to use strain-specific barcoding for taxonomic analysis of Lacticaseibacillus paracasei and assess its potential as a probiotic, including its presence in the human gut microbiome under various conditions.", "results_summary": "The study identified four L. paracasei phylogroups and reclassified L. casei 12A as belonging to one of them. It also found that antibiotics significantly affected L. paracasei presence in the gut microbiome, with strain-specific barcoding revealing adaptive responses.", "population_specificity": "Human gut microbiome (metagenomic analysis)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:46.375155+00:00"}
{"study_id": 22680, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lacticaseibacillus paracasei NK112 could alleviate depression and cognitive impairment by suppressing IL-6 expression and modulating gut microbiota.", "results_summary": "Oral administration of NK112 significantly reduced anxious, depressive, and memory-impaired behaviors in mice, suppressed inflammatory markers (IL-6, TNF-\u03b1, NF-\u03baB), and improved gut microbiota composition. Heat-killed NK112 and its lysate fractions also showed similar therapeutic effects.", "population_specificity": "C57 BL/6J mice with induced depression and cognitive impairment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:48.719107+00:00"}
{"study_id": 22681, "supplement_id": 1272, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Lacticaseibacillus paracasei strain Shirota (LcS) alleviates constipation and improves depressive symptoms in patients with depression.", "results_summary": "LcS did not significantly improve overall constipation symptoms but alleviated specific rectal and stool symptoms. It also improved depressive symptoms and reduced IL-6 levels more than placebo, while modulating gut microbiota linked to mental illness.", "population_specificity": "82 patients with constipation and depression.", "effective_dosage": "100 mL of LcS beverage (10^8 CFU/mL) daily.", "study_duration": "9 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:50.427936+00:00"}
{"study_id": 22682, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Lacticaseibacillus paracasei MG5012 on insulin resistance and diabetes-related metabolic changes in both in vitro (HepG2 cells) and in vivo (high-fat diet-induced mice) models.", "results_summary": "L. paracasei MG5012 improved glucose uptake and glycogen content in insulin-resistant HepG2 cells and reduced body weight, glucose tolerance, and metabolic markers (e.g., serum glucose, insulin, triglycerides) in mice. It also enhanced PI3K/Akt expression in the liver, indicating improved insulin signaling.", "population_specificity": "High-fat diet-induced mice and palmitic acid-induced insulin-resistant HepG2 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:52.176825+00:00"}
{"study_id": 22683, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate whether Lacticaseibacillus paracasei strain Shirota (LcS) could alleviate depressive symptoms in patients with major depressive disorder (MDD) or bipolar disorder (BD) and its association with gut microbiota.", "results_summary": "LcS treatment significantly alleviated depression severity, with effects linked to higher counts of Bifidobacterium and Atopobium clusters in the gut microbiota. No significant changes were observed in intestinal permeability or inflammation markers.", "population_specificity": "18 patients with MDD or BD (14 females, 4 males; 15 MDD, 3 BD).", "effective_dosage": "8.0 \u00d7 10^10 colony-forming units daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:53.392086+00:00"}
{"study_id": 22684, "supplement_id": 1272, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Lacticaseibacillus paracasei Lpc-37\u00ae could modulate stress, mood, and well-being in healthy adults under chronic stress.", "results_summary": "Lpc-37 reduced perceived stress overall, with differential effects based on chronic stress levels and sex\u2014lowering heart rate in low-stress participants and increasing it in high-stress participants during stress tests, while also improving cortisol levels, exhaustion, and sleep-related recovery in subgroups. The primary hypothesis on heart rate modulation was not met.", "population_specificity": "120 healthy adults (18-45 years), stratified by sex and chronic stress levels.", "effective_dosage": "1.75 \u00d7 10^10 CFU per day.", "study_duration": "5 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:54.798570+00:00"}
{"study_id": 192598, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 80, "study_goal": "The researchers aimed to determine whether oral probiotic supplementation with Lacticaseibacillus paracasei could prevent vulvovaginal infections (VVIs) in pregnant women with normal vaginal flora.", "results_summary": "The study found no significant difference in the rate of VVIs between the probiotic and placebo groups, indicating that the probiotic did not reduce the incidence of infections. The tested oral probiotic product was ineffective in preventing VVIs in the studied population.", "population_specificity": "Pregnant women with normal vaginal flora (Nugent score < 4 and no candida).", "effective_dosage": "2 capsules/day (specific strain count not provided).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:55.285109+00:00"}
{"study_id": 192600, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Lacticaseibacillus paracasei has anti-inflammatory and muscle damage-ameliorating properties.", "results_summary": "The study demonstrated that Lacticaseibacillus paracasei exhibited anti-inflammatory effects and helped alleviate muscle damage, though specific results were not detailed in the abstract.", "population_specificity": "Athletes and sports enthusiasts (specific details not provided).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:55.823914+00:00"}
{"study_id": 22685, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antimicrobial activity of bacteriocins produced by Lacticaseibacillus paracasei CNCM I-5369 against Gram-negative bacteria, particularly Escherichia coli carrying the mcr-1 gene, and assess the enhanced efficacy when these bacteriocins were loaded onto alginate nanoparticles.", "results_summary": "The study found that semi-purified bacteriocins (E20) from Lacticaseibacillus paracasei exhibited antimicrobial activity against E. coli, with MIC values ranging from 250 to 2000 \u03bcg/mL. Loading E20 onto alginate nanoparticles (Alg NPs/E20) significantly improved efficacy, reducing MIC values to 2-4 \u03bcg/mL, a 500-fold increase in anti-E. coli activity.", "population_specificity": "Not specified (in vitro study targeting Gram-negative bacteria, particularly E. coli).", "effective_dosage": "E20: 250-2000 \u03bcg/mL; Alg NPs/E20: 2-4 \u03bcg/mL.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:57.327350+00:00"}
{"study_id": 192602, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate compositional and functional changes in the fecal microbiome of healthy adults after supplementation with a 14-strain probiotic blend, including Lacticaseibacillus paracasei.", "results_summary": "The study found no significant changes in overall microbiome diversity but observed modest compositional changes at the family and genus levels, along with changes in gene abundance for several functional pathways.", "population_specificity": "Healthy young adults", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:58.320615+00:00"}
{"study_id": 192606, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the strain-specific influence of Lacticaseibacillus paracasei in preventing gastrointestinal tract infections (GITIs) among infants and children attending childcare centers.", "results_summary": "The study found that Lacticaseibacillus paracasei was one of the specifically potent probiotic strains in reducing GITI episodes, with an overall 26% reduction in risk. The review pooled data from 15 eligible RCTs, indicating its effectiveness in this context.", "population_specificity": "Infants and children attending childcare centers.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:00.436484+00:00"}
{"study_id": 192607, "supplement_id": 1272, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of 24-week synbiotic supplementation (potentially including Lacticaseibacillus paracasei) on chronic inflammation and gut microbiota in obese patients with type 2 diabetes.", "results_summary": "The abstract does not provide specific results regarding Lacticaseibacillus paracasei's effects.", "population_specificity": "Obese patients with type 2 diabetes (n=88).", "effective_dosage": "Not specified.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:01.257357+00:00"}
{"study_id": 21637, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Lactobacillus acidophilus as an adjunct therapy for alleviating gastrointestinal symptoms in COVID-19 patients by assessing its effects on gut microbiota balance and inflammation markers.", "results_summary": "The study found that L. acidophilus supplementation may help resolve diarrhea faster, improve gut microbiota balance, and reduce inflammatory markers, though it did not significantly impact hospitalization rates or disease progression. Some strains showed promise, but clinical validation requires further preclinical studies.", "population_specificity": "COVID-19 patients with gastrointestinal symptoms.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:02.987553+00:00"}
{"study_id": 21636, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic potential of Lactobacillus acidophilus LA85 in a mouse model of streptozotocin-induced diabetic neuropathy, focusing on pain management and glycemic control.", "results_summary": "LA85, particularly at 1.0 \u00d7 10^9 CFU, significantly reduced neuropathy signs, improved redox and immune homeostasis in the spinal cord, and showed no motor impairment. It reduced interleukin-1\u03b2, malondialdehyde, and nitrite levels.", "population_specificity": "Male C57BL/6 mice with streptozotocin-induced diabetic neuropathy.", "effective_dosage": "1.0 \u00d7 10^7 or 1.0 \u00d7 10^9 CFU daily.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:03.772700+00:00"}
{"study_id": 21638, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the therapeutic potential of Lactobacillus acidophilus extracellular vesicles (EVs) combined with TNF-\u03b1 siRNA for treating ulcerative colitis (UC) through gut microecology modulation, immune regulation, and gene silencing.", "results_summary": "The study found that the EVs@UiO-66-NH2@siRNA system effectively delivered TNF-\u03b1 siRNA to colon tissues, reduced inflammation in a DSS-induced UC model, and modulated gut microbiota and metabolites toward an anti-inflammatory phenotype. The system also demonstrated high siRNA loading capacity and pH-responsive release.", "population_specificity": "DSS-induced ulcerative colitis model (animal study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:04.578932+00:00"}
{"study_id": 21640, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Lactobacillus acidophilus on growth performance, carcass characteristics, immune function, and underlying mechanisms in broiler chickens.", "results_summary": "L. acidophilus supplementation improved feed efficiency, reduced abdominal fat percentage, and enhanced immune function by increasing HDL-C, IL-2, IL-4 levels, and decreasing LPS in broiler serum.", "population_specificity": "1-day-old AA broiler chickens", "effective_dosage": "1.0 \u00d7 10^8 CFU/kg", "study_duration": "Whole experimental period (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:06.202118+00:00"}
{"study_id": 21639, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of Lactobacillus acidophilus, both viable and non-viable, in reducing Aflatoxin M1 (AFM1) in yoghurt and explore its potential in combination with other strains and encapsulation techniques.", "results_summary": "Lactobacillus acidophilus showed the highest efficacy in reducing AFM1 among the studied strains, with encapsulated forms achieving significant reductions (68% and 81%) from the first day of storage. The combination of L. acidophilus with other strains further enhanced AFM1 reduction, reaching 90% in acid-treated co-culture.", "population_specificity": "Dairy food (yoghurt)", "effective_dosage": "Not specified", "study_duration": "Two weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:06.511387+00:00"}
{"study_id": 21642, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers investigated the effects of hydrothermal treatment and low pH conditions on Maitake to enhance bioactive polysaccharide extraction and metabolite bioavailability.", "results_summary": "The study found that hydrothermal treatment and low pH significantly altered Maitake's structure, increasing \u03b2-glucan yield and antioxidant activity while reducing surface hydrophobicity. Metabolomic analysis confirmed pathway alterations, validating the effectiveness of these treatments in enriching Maitake's medicinal properties.", "population_specificity": "Not specified (in vitro or biochemical study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:08.347291+00:00"}
{"study_id": 21641, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of Lactobacillus acidophilus in modulating the antitumor efficacy of oncolytic virotherapy (VSV\u039451) and its impact on gut microbiota homeostasis.", "results_summary": "The study found that VSV\u039451 reduced Lactobacillus acidophilus colonization by disrupting SLC20A1 expression via IL6-JAK-STAT3 signaling. Supplementation with L. acidophilus restored gut barrier integrity and microbiota homeostasis, enhancing VSV\u039451's antitumor efficacy.", "population_specificity": "Female mouse models with hepatocellular carcinoma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:08.475354+00:00"}
{"study_id": 21643, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lactobacillus acidophilus, alone or combined with Balanites aegyptiaca, could reduce hyperglycemia, oxidative stress, and inflammation in diabetic rats.", "results_summary": "The combination of Lactobacillus acidophilus and Balanites aegyptiaca significantly reduced blood glucose levels, enhanced antioxidant enzyme activities, decreased pro-inflammatory cytokines, and improved lipid profiles in diabetic rats. The combined treatment outperformed either treatment alone.", "population_specificity": "Alloxan-induced diabetic male rats (100-110 g; 8-10 weeks old).", "effective_dosage": "28.5 mg/kg twice daily.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:11.887510+00:00"}
{"study_id": 21645, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether early intervention with Lactobacillus acidophilus (LA) could alleviate inflammation and oxidative stress caused by S. Typhimurium infection in mice and explore the underlying mechanisms.", "results_summary": "LA early intervention reduced pathological injury, increased antioxidant enzyme expression, decreased inflammatory markers (MDA, IL-8, TNF-\u03b1), modulated gut microbiota, and activated the p62-Keap1-Nrf2 signaling pathway in S. Typhimurium-infected mice.", "population_specificity": "Laboratory mice infected with S. Typhimurium", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:12.637916+00:00"}
{"study_id": 21644, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the antibacterial and anti-biofilm properties of carbon dots derived from Lactobacillus acidophilus (L-C-dots) against carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates, both alone and in combination with meropenem.", "results_summary": "L-C-dots showed significant antibacterial activity against CRKP isolates, inhibited biofilm formation, and had synergistic/additive effects with meropenem. They also reduced the expression of biofilm-associated genes (fimH and mrkD).", "population_specificity": "Seventy clinical isolates of Klebsiella pneumoniae (carbapenem-resistant).", "effective_dosage": "Minimum inhibitory concentration (MIC) of 50 mg/mL; sub-MIC of 25 mg/mL.", "study_duration": "Not specified.", "interactions": "Synergistic/additive interaction with meropenem.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:13.756028+00:00"}
{"study_id": 21646, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential of Lactobacillus acidophilus YL01 and its exopolysaccharide (EPS) in alleviating obesity, insulin resistance, and related metabolic disorders, as well as to explore their mechanisms of action.", "results_summary": "L. acidophilus YL01 and its EPS significantly reduced body weight, fat accumulation, fasting blood glucose, and insulin resistance in high-fat diet mice, while also improving dyslipidemia, liver function, and inflammation. The study identified EPS as an acidic polysaccharide and suggested its effects were mediated through gut microbiota modulation and activation of the AMPK/ACC pathway.", "population_specificity": "High-fat diet-induced obese mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:14.382733+00:00"}
{"study_id": 21647, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic and prophylactic effectiveness of Lactobacillus acidophilus against Blastocystis ST3 infection in rats, comparing it to metronidazole (MTZ) and assessing immunomodulatory effects.", "results_summary": "L. acidophilus showed a 76% reduction in fecal parasitic count and 67% clearance in intestinal wash, comparable to MTZ, with immunomodulatory effects (upregulated IL-10, downregulated TNF-\u03b1). Combined MTZ and L. acidophilus achieved 99% fecal and 98% intestinal parasitic reduction, while prophylactic use was ineffective.", "population_specificity": "Rats experimentally infected with Blastocystis subtype 3 (ST3).", "effective_dosage": "Not specified", "study_duration": "Not specified (prophylactic use was for 7 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:15.805703+00:00"}
{"study_id": 21649, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a synbiotic formulation of BLEPS-1 and Lactobacillus acidophilus could alleviate intestinal inflammation and modulate gut microbiota in a DSS-induced ulcerative colitis mouse model.", "results_summary": "The combination of BLEPS-1 and L. acidophilus reduced intestinal inflammation more effectively than either component alone, modulated macrophage polarization toward the M2-type, and altered gut microbiota composition and metabolic profiles. L. acidophilus specifically promoted metabolism of aromatic amino acids.", "population_specificity": "DSS-induced ulcerative colitis mouse model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:16.169744+00:00"}
{"study_id": 21648, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antimicrobial properties of Lactobacillus acidophilus (LA) metabolites and extracellular vesicles against common equine endometrial pathogenic bacteria, including multidrug-resistant E. coli.", "results_summary": "LA total metabolites showed strong inhibition against A. baumannii, E. coli (1), and E. cloacae, while LA extracellular vesicles were more effective than low molecular weight metabolites in inhibiting E. coli (2). LA demonstrated potential for controlling endometritis in mares.", "population_specificity": "Mares with endometritis or at risk of endometrial infections.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:16.460483+00:00"}
{"study_id": 22670, "supplement_id": 1272, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to characterize the antimicrobial compound (bacteriocin) produced by Lacticaseibacillus paracasei F9-02 isolated from breast-fed infants' feces and assess its therapeutic potential.", "results_summary": "The study found that L. paracasei F9-02 produces a bacteriocin with strong antimicrobial activity against multiple clinical pathogens, including MRSA and VRE, and demonstrated stability under various physicochemical conditions. The bacteriocin was also non-cytotoxic, non-hemolytic, and retained activity across a broad pH and temperature range.", "population_specificity": "Breast-fed infants (fecal isolate source)", "effective_dosage": "Minimum inhibitory concentration (MIC) values ranged from 7.56 \u03bcg/ml to 30.25 \u03bcg/ml depending on the pathogen.", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:19.446492+00:00"}
{"study_id": 21651, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of Lactobacillus acidophilus combined with montmorillonite powder on inflammatory response and symptom relief in children with rotavirus enteritis.", "results_summary": "The study found that Lactobacillus acidophilus combined with montmorillonite significantly improved clinical efficacy, shortened symptom relief time, and reduced inflammatory markers (CRP) compared to montmorillonite alone, with a higher incidence of mild adverse reactions (not statistically significant).", "population_specificity": "Children with rotavirus enteritis (94 participants, aged not specified).", "effective_dosage": "Not specified (compound L. acidophilus tablets).", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:19.548264+00:00"}
{"study_id": 21652, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Lactobacillus acidophilus on immunoantioxidant status, growth, digestive function, and resistance to Aeromonas hydrophila in Cyprinus carpio juveniles.", "results_summary": "Lactobacillus acidophilus (especially at 3 \u00d7 10^8 CFU/g) improved immune and antioxidant parameters, reduced oxidative stress markers, and enhanced resistance to A. hydrophila infection. It also positively influenced digestive enzyme activity and mucosal immunity.", "population_specificity": "Cyprinus carpio (common carp) juveniles", "effective_dosage": "1.5 \u00d7 10^8 CFU/g (LA1.5) and 3 \u00d7 10^8 CFU/g (LA3) per kg of diet", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:21.205146+00:00"}
{"study_id": 21653, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the chemopreventive effects of Lactobacillus acidophilus, calcium citrate, and Moringa oleifera extract against DMH-induced colon cancer in rats.", "results_summary": "Combined treatment with Lactobacillus acidophilus, calcium citrate, and Moringa oleifera extract significantly reduced aberrant crypt foci (ACFs) count and improved liver histology, with no adverse effects on liver or kidney function biomarkers.", "population_specificity": "Sprague Dawley rats with DMH-induced colon cancer.", "effective_dosage": "Lactobacillus acidophilus (10^9 cfu p.o.), calcium citrate (2 mg/kg p.o.), Moringa oleifera extract (100 & 200 mg/kg p.o.).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:22.196639+00:00"}
{"study_id": 21654, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the performance of postbiotics derived from Lactobacillus acidophilus as an alternative to antibiotics in broiler chickens.", "results_summary": "Postbiotic supplementation at 0.2% significantly improved body weight, feed conversion ratio, immune response, gut morphology, and antioxidant activity while reducing harmful bacterial counts. The study concluded that 0.2% postbiotics could replace antibiotic growth promoters in broilers.", "population_specificity": "Slow-growing broiler chicks (CARI-Bro Dhanraja)", "effective_dosage": "0.2%, 0.4%, and 0.6% (v/w) postbiotic supplementation in feed", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:22.827815+00:00"}
{"study_id": 21656, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of frozen storage on acidophilus milk quality, L. acidophilus viability, and its cholesterol-lowering potential in Wistar rats.", "results_summary": "Acidophilus milk maintained quality in frozen storage for two months, with stable pH, protein, and lactic acid levels. Consumption for 15 days reduced cholesterol levels in Wistar rats, with effects lasting up to 30 days.", "population_specificity": "Wistar rats", "effective_dosage": "Not specified", "study_duration": "15 days of consumption, effects monitored up to 30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:23.375930+00:00"}
{"study_id": 21655, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the functional and molecular gastrointestinal responses to a synbiotic combining chitin-glucan (CG) and Lactobacillus acidophilus NCFM in a rat model of long-lasting colon hypersensitivity.", "results_summary": "The combination of CG 1.5 g and NCFM 10^9 CFU significantly decreased visceral pain perception and intestinal inflammation, outperforming either component alone. The synbiotic treatment reduced colonic lesions, myeloperoxidase concentrations, and inflammatory cytokines while inducing analgesic genes and anti-inflammatory IL-10.", "population_specificity": "Rat model of long-lasting colon hypersensitivity", "effective_dosage": "CG 1.5 g + NCFM 10^9 CFU", "study_duration": "9 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:25.709933+00:00"}
{"study_id": 21657, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to improve the survival rate, antibacterial activity, and polyunsaturated fatty acids (PUFAs) content of Lactobacillus acidophilus LB when cultured in an algae-supplemented medium for aquaculture applications.", "results_summary": "Spirulina platensis promoted the highest density of L. acidophilus LB, which produced high lactic acid concentration (18.24 \u00b1 2.43 mg/mL), survived extreme conditions (4% NaCl, pH 1.0-2.0, 50 \u00baC), and inhibited 99.82 \u00b1 0.24% of Vibrio parahaemolyticus. PUFAs content, specifically omega-6 and -7, also increased compared to the control.", "population_specificity": "Aquatic species (aquaculture applications)", "effective_dosage": "Not specified", "study_duration": "2 days (for antibacterial activity assessment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:26.010977+00:00"}
{"study_id": 21660, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the effects and mechanisms of Lactobacillus acidophilus on cholestatic liver injury in mice and humans, focusing on gut microbiota modulation and bile acid metabolism.", "results_summary": "L. acidophilus administration attenuated hepatic injury in mice, reduced liver bile acids, and increased fecal bile acids. In cholestatic patients, it promoted liver function recovery, correlating with changes in bile acid profiles and gut microbiota composition.", "population_specificity": "Mice with bile duct ligation-induced cholestatic liver injury and cholestatic human patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:28.712568+00:00"}
{"study_id": 21661, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the mechanisms by which Lactobacillus acidophilus strain LA1 protects against TNF-\u03b1-induced increases in intestinal epithelial tight junction permeability.", "results_summary": "LA1 prevented TNF-\u03b1-induced increases in intestinal epithelial tight junction permeability by inhibiting NF-\u03baB p50/p65 and MLCK activation via TLR-2-dependent pathways. The effects were mediated through PI3K and IKK-\u03b1 phosphorylation.", "population_specificity": "Cell culture (Caco-2 monolayers) and animal models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:29.426612+00:00"}
{"study_id": 21662, "supplement_id": 1273, "safety_score": "70", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of Lactobacillus acidophilus probiotics on calcium levels, bone metabolism biomarkers, and bone mineral density in postmenopausal women.", "results_summary": "The probiotic group showed decreased serum calcium levels but no notable changes in hair calcium or bone metabolism biomarkers. Probiotic intake stabilized bone turnover markers, reduced body and visceral fat, but increased glucose concentration.", "population_specificity": "Postmenopausal women", "effective_dosage": "Daily oral intervention (specific dosage not mentioned)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:29.840287+00:00"}
{"study_id": 21663, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether preemptive oral administration of Lactobacillus acidophilus could protect against Corynebacterium pseudotuberculosis infection in mice by modulating macrophage autophagy and preserving gut microbiota stability.", "results_summary": "The study found that L. acidophilus significantly reduced pathological damage, enhanced bacterial clearance by macrophages, and maintained gut microbiota homeostasis in C. p-infected mice. The protective effects were linked to increased LC3-II protein expression, indicating enhanced autophagy.", "population_specificity": "C57BL/6 mice infected with Corynebacterium pseudotuberculosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:30.815651+00:00"}
{"study_id": 21664, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of a food supplement containing Lactobacillus acidophilus, bioactive peptides, and vitamins in relieving heartburn/dyspeptic symptoms in subjects with mild-to-moderate GERD.", "results_summary": "The food supplement significantly reduced heartburn frequency and severity, decreased OTC medication intake, and improved quality of life scores compared to placebo. The effects were progressive and statistically significant.", "population_specificity": "56 adult participants with mild-to-moderate GERD.", "effective_dosage": "Not specified", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:32.672921+00:00"}
{"study_id": 21665, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of solid-state fermentation with Lactobacillus acidophilus on reducing anti-nutritional factors and improving the nutritional quality of soybean meal.", "results_summary": "Fermentation with L. acidophilus reduced trypsin inhibitor levels by over 90%, increased protein content, and degraded high-molecular-weight immunogenic proteins. L. acidophilus dominated the bacterial community and inhibited undesirable bacteria.", "population_specificity": "Soybean meal (not human or animal subjects)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:33.332914+00:00"}
{"study_id": 21667, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antiproliferative effect of Lactobacillus acidophilus on oral squamous cell carcinoma (OSCC) and assess whether Streptococcus mutans influences this effect.", "results_summary": "L. acidophilus significantly reduced the viability of OSCC cells (53%-56%) and increased TRAIL gene and protein expression, suggesting a TRAIL-induced apoptosis mechanism. The presence of S. mutans did not diminish L. acidophilus's antiproliferative activity.", "population_specificity": "Human head and neck squamous cell carcinoma cells (HNO97 cell line).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:37.175369+00:00"}
{"study_id": 21666, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lactobacillus acidophilus YBS1 could inhibit adipogenesis in 3T3-L1 cells as a potential anti-obesity supplement.", "results_summary": "YBS1 significantly reduced triglyceride accumulation and suppressed PPAR\u03b3 expression, inhibiting early-stage adipocyte differentiation via p38 MAPK activation. No significant effects were observed during mid- or late-stage adipogenesis.", "population_specificity": "3T3-L1 cells (mouse pre-adipocyte cell line)", "effective_dosage": "Not specified", "study_duration": "Days 0-6 (early, mid, and late stages of adipogenesis)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:37.807661+00:00"}
{"study_id": 21668, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the mode of action of Lactobacillus acidophilus AG01 in reducing the pathogenicity of Clostridium perfringens in poultry intestinal diseases.", "results_summary": "The study found that Lactobacillus acidophilus AG01, alongside Bifidobacterium animalis subsp. lactis AG02, alleviated the cytotoxicity of all tested C. perfringens strains in a dose-dependent manner, though it did not reduce cell adhesion as effectively as B. animalis subsp. lactis AG02.", "population_specificity": "Poultry intestinal epithelial cells (CHIC-8E11 cell line) challenged with C. perfringens strains.", "effective_dosage": "Cell-free supernatants (CFS) dosed at 50 \u00b5L/mL.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:39.020429+00:00"}
{"study_id": 21669, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 78, "quality_score": 72, "study_goal": "The researchers aimed to investigate the synbiotic relationship between p-coumaric acid (p-CA) and Lactobacillus acidophilus LA-5 (LA-5), focusing on how p-CA affects probiotic properties, growth, and interactions with gut microbiota.", "results_summary": "The study found that p-CA did not inhibit the growth of LA-5 and enhanced its auto-aggregation, antibacterial properties, and resistance to pepsin and bile salt. Additionally, LA-5 combined with p-CA showed significant inhibition of AChE and BChE activities.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Different concentrations of p-CA (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:39.624307+00:00"}
{"study_id": 21670, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if coadministration of Lactobacillus acidophilus with doxorubicin and vitamin D3 could reduce tumor size, protect intestinal tissue, and influence gene expression in breast cancer treatment.", "results_summary": "The study found that Lactobacillus acidophilus, when combined with doxorubicin and vitamin D3, significantly reduced tumor volume and weight, lowered chemotherapy toxicity, and influenced gene expression (increased Bax/Caspase 3 and decreased Bcl-2).", "population_specificity": "Female BALB/c inbred mice with induced 4T1 mouse carcinoma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:40.683969+00:00"}
{"study_id": 21671, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the role and molecular mechanisms of Lactobacillus acidophilus and its metabolite butyrate in alleviating postmenopausal osteoporosis (PMOP) by inhibiting osteoclast formation and bone resorption.", "results_summary": "The study found that Lactobacillus acidophilus and butyrate significantly inhibited osteoclast formation and bone resorption, improved intestinal barrier permeability, and reduced systemic bone loss in PMOP. Butyrate, regulated by L. acidophilus, directly inhibited osteoclast activity in vitro.", "population_specificity": "Postmenopausal osteoporosis (PMOP) patients.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:41.488553+00:00"}
{"study_id": 21673, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the role of Lactobacillus acidophilus in improving hypoallergenicity and digestibility of a corn-soybean meal mixture through two-stage fermentation.", "results_summary": "Lactobacillus acidophilus NCUA065016, combined with Bacillus subtilis NCUBSL003, significantly reduced antinutritional factors and allergenic proteins while increasing small peptides and free amino acids. Pathogenic bacteria were effectively inhibited during fermentation.", "population_specificity": "Corn-soybean meal mixture (in vitro fermentation study, not human or animal subjects).", "effective_dosage": "Inoculum 7.14%, solid-liquid ratio 1:0.88.", "study_duration": "74.30 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:46.139457+00:00"}
{"study_id": 21674, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the antibacterial effects of bamboo shoot ethanolic extract and chlorhexidine mouth rinse on Lactobacillus acidophilus and Streptococcus mutans in saliva.", "results_summary": "Bamboo shoot ethanolic extract at 60 \u00b5g/ml showed significant antibacterial activity against L. acidophilus, with inhibition zones comparable to chlorhexidine. The extract was equally effective against both bacterial species.", "population_specificity": "30 young adults", "effective_dosage": "30 \u00b5g/ml, 40 \u00b5g/ml, 50 \u00b5g/ml, and 60 \u00b5g/ml (single ex vivo treatment)", "study_duration": "Not specified (ex vivo study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:46.964430+00:00"}
{"study_id": 21676, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether selenium nanoparticles (SeNPs) produced by Lactobacillus acidophilus HN23 could effectively reduce lipid deposition and oxidative damage in a fatty liver cell model.", "results_summary": "The study found that SeNPs produced by L. acidophilus were less toxic than selenite and more effective in reducing lipid deposition, increasing mitochondrial membrane potential, and enhancing antioxidant capacity in WRL68 fatty liver cells.", "population_specificity": "In vitro WRL68 fatty liver cell model.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:47.389434+00:00"}
{"study_id": 21675, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus acidophilus KBL409 on atopic dermatitis (AD) by modulating immune responses and gut microbiota in a house dust mite-induced AD mouse model.", "results_summary": "L. acidophilus KBL409 significantly reduced dermatitis scores, immune cell infiltration, and serum IgE levels while modulating cytokine profiles and gut microbiota. It also increased anti-inflammatory IL-10 and Foxp3 expression, suggesting potential benefits for AD treatment.", "population_specificity": "House dust mite-induced AD mouse model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:47.864155+00:00"}
{"study_id": 21677, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether the gut microbiota and its metabolites play a key role in Lactobacillus acidophilus's therapeutic mechanisms for ulcerative colitis (UC) and how they modulate intestinal immunity.", "results_summary": "The study found that Lactobacillus acidophilus significantly improved UC severity and immune regulation in mice, with its therapeutic effects linked to gut microbiota and the metabolite ursodeoxycholic acid (UDCA). UDCA promoted Treg cell differentiation, reduced pro-inflammatory cytokines, and acted via the RapGap/PI3K-AKT/NF-\u03baB pathway.", "population_specificity": "UC-induced mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:48.513949+00:00"}
{"study_id": 21659, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the antihypertensive activity of a synbiotic preparation containing Lactobacillus acidophilus and explore its underlying mechanisms.", "results_summary": "The synbiotic preparation significantly lowered systolic blood pressure in rats, activated the PPAR signaling pathway, upregulated PPAR\u03b2 and PPAR\u03b3, and altered intestinal microbiota composition. It also increased lysophosphatidylethanolamine and phosphatidylcholine levels in the ileum.", "population_specificity": "Rats with hypertension", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:49.513177+00:00"}
{"study_id": 21678, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anticancer effects of Lactobacillus acidophilus supernatant on colorectal cancer cell lines, focusing on gene expression and microRNA profiles related to apoptosis, cell cycle, and metastasis.", "results_summary": "The study found that Lactobacillus acidophilus supernatant suppressed colorectal cancer cell proliferation, upregulated pro-apoptotic genes (BAX, CASP3, CASP9), downregulated anti-apoptotic and metastatic genes (BCl-2, MMP2, MMP9), and altered microRNA expression profiles to favor tumor suppression.", "population_specificity": "Colorectal cancer cell lines (HT29 and SW480).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:50.258743+00:00"}
{"study_id": 21658, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of heat-killed Lactobacillus acidophilus IFFI 6005 on growth performance, gut microbiota, and fecal metabolites in piglets, comparing it to live probiotics and antibiotics.", "results_summary": "Heat-killed Lactobacillus acidophilus IFFI 6005 improved feed efficiency, reduced diarrhea rates, increased daily weight gain, enhanced gut microbial diversity, and reduced pathogenic bacteria without affecting Lactobacillus abundance. It showed comparable efficacy to antibiotics in some metrics.", "population_specificity": "Weaned piglets (initial weight 14.38 \u00b1 0.67 kg, 40 days old).", "effective_dosage": "600 g/t (1.0 \u00d7 10^10 cfu/g equivalent).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:51.116193+00:00"}
{"study_id": 21682, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of Lactobacillus acidophilus LB as an adjunctive treatment for ADHD symptomatology and its influence on cognitive function in children and adolescents.", "results_summary": "The probiotic group showed significant improvements in ADHD symptoms (measured by CPRS-R-L and CBCL scores) and cognitive performance (focus attention and reduced errors in WCST) compared to the control group after 3 months.", "population_specificity": "Children and adolescents aged 6-16 years with ADHD diagnosis.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "Combined with atomoxetine (no adverse interactions mentioned)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:55.931446+00:00"}
{"study_id": 21679, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the viability of Lactobacillus acidophilus in synbiotic yogurt sauce containing Spirulina platensis microalgae extract (SPAE) and assess its chemical, rheological, and sensory properties over storage.", "results_summary": "The study found that higher SPAE concentrations (1-2%) significantly improved L. acidophilus viability, with the 2% treatment showing the least reduction in bacterial count. Acidity increased, while pH, viscosity, and sensory properties decreased over storage compared to the control.", "population_specificity": "Not specified (likely general population, given the food product focus).", "effective_dosage": "0.5%, 1%, and 2% SPAE in yogurt sauce.", "study_duration": "35 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:56.109411+00:00"}
{"study_id": 21680, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of postbiotics from Lactobacillus acidophilus on colorectal cancer (CRC) by examining its impact on key genes in the Wnt pathway and its anti-proliferative and anti-migration effects on HT-29 cells.", "results_summary": "L. acidophilus postbiotics induced cell cycle arrest at the G1 phase, exhibited anti-proliferative and anti-migration effects on HT-29 cells, and modulated key genes in the Wnt pathway, suggesting therapeutic potential for CRC. No anti-proliferative activity was observed in control fibroblasts.", "population_specificity": "HT-29 cells (a human colorectal adenocarcinoma cell line) and control fibroblasts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:56.219826+00:00"}
{"study_id": 21683, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate how Lactobacillus acidophilus (LA) interacts with Veillonella ratti (V. ratti) and alleviates dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) in a mouse model.", "results_summary": "Co-culturing LA with V. ratti increased lactic acid and SCFA production while reducing glucose levels. In vivo, LA combined with V. ratti alleviated UC symptoms, reduced inflammation, and improved gut microbiota balance.", "population_specificity": "C57BL/6 mice with DSS-induced colitis.", "effective_dosage": "1 \u00d7 10^9 CFU mL-1 per day per mouse.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:56.220459+00:00"}
{"study_id": 21684, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Lactobacillus acidophilus LA11-Only could repair ceftriaxone-induced intestinal microbiota imbalance and improve lipid metabolism in mice.", "results_summary": "LA11-Only increased intestinal microbiota diversity, boosted beneficial bacteria (e.g., Lactobacillus and Butyricicoccus), and elevated short-chain fatty acid levels, particularly butyric and valeric acids, bringing them closer to control group levels.", "population_specificity": "SPF BALB/c male mice", "effective_dosage": "1.0\u00d710^9 CFU/mL in skimmed milk solution", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:56.458333+00:00"}
{"study_id": 21685, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify strains of Lactobacillus acidophilus with potential probiotic activity using pangenomic, metabolic annotation, and machine-learning-based analyses.", "results_summary": "L. acidophilus NCTC 13721 showed the greatest probiotic potential among 64 tested strains, with high gene involvement in organic acid metabolism and quorum sensing. DSM 20079 also demonstrated promise, while eight strains showed near-100% genomic similarity to La-5.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:56.975398+00:00"}
{"study_id": 21686, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of electrospun fibers containing Lactobacillus acidophilus as an alternative to daily probiotic administration for bacterial vaginosis prevention and treatment.", "results_summary": "The study found that Lactobacillus acidophilus incorporated in electrospun fibers produced high levels of lactic acid, significantly reduced pH, and demonstrated strong inhibition of Gardnerella viability, indicating metabolic activity and potential efficacy against bacterial vaginosis.", "population_specificity": "Not specified (in vitro study).", "effective_dosage": "108\u2013109 CFU probiotic/mg fiber, with daily recovery on the order of 108 CFU/(mg\u00b7day).", "study_duration": "Evaluated after 48 hours and 6 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:58.154671+00:00"}
{"study_id": 21687, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate how different metal ion pre-stress affects the acid tolerance and survival ability of Lactobacillus acidophilus CICC 6074.", "results_summary": "The study found that metal ion pre-stress, particularly Mn2+, improved the acid tolerance of L. acidophilus by enhancing cell morphology, reducing membrane damage, and regulating surface protein expression. Proteomic analysis revealed Mn2+ pre-stress activated DNA replication, RNA synthesis, and other protective mechanisms.", "population_specificity": "Lactobacillus acidophilus CICC 6074 (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:59.874845+00:00"}
{"study_id": 21688, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To determine the role of Lactobacillus acidophilus and other probiotic strains in inhibiting H. pylori colonization and reducing gastric inflammation.", "results_summary": "L. acidophilus NCFM and L. plantarum Lp-115 significantly reduced H. pylori adhesion and inflammation in both in vitro and in vivo models, lowering IL-8 and TNF-\u03b1 levels and decreasing inflammatory cell infiltration.", "population_specificity": "Human gastric adenocarcinoma AGS cells and male C57BL/6 mice.", "effective_dosage": "Not specified", "study_duration": "Six weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:03.147832+00:00"}
{"study_id": 21690, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate whether Lactobacillus acidophilus LA85 could alleviate colitis symptoms in mice by regulating immune responses and restoring gut microbiota.", "results_summary": "L. acidophilus LA85 significantly reduced colitis symptoms, improved gut microbiota diversity, and modulated inflammatory cytokines, demonstrating potential for treating ulcerative colitis.", "population_specificity": "C57BL/6J male mice with DSS-induced ulcerative colitis.", "effective_dosage": "1 \u00d7 10^9 colony-forming units/day.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:03.619549+00:00"}
{"study_id": 21691, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the therapeutic effects of Lactobacillus acidophilus (LA-5\u00ae) and Lactobacillus johnsonii (B-2178) on vulvovaginal candidiasis (VVC) in a rat model, focusing on immune response and vaginal epithelium restoration.", "results_summary": "Lactobacillus acidophilus significantly reduced Candida albicans vaginal load and pro-inflammatory cytokines (IL-17 and IFN-\u03b3) but was less effective than L. johnsonii in restoring vaginal architecture and reducing hyphae formation.", "population_specificity": "Female Sprague-Dawley rats subjected to ovariectomy and C. albicans infection.", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:04.159595+00:00"}
{"study_id": 21689, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to optimize the production of LA-EPS-20079 from Lactobacillus acidophilus and evaluate its cytotoxic effects against colon cancer cells (CaCo-2).", "results_summary": "The optimized LA-EPS-20079 showed significant cytotoxic effects against CaCo-2 cells (64.6-81.9% inhibition) and downregulated BCL2 and Survivin gene expression. The maximum LA-EPS-20079 concentration achieved was 794.82 \u03bcg/ml under optimal conditions.", "population_specificity": "In vitro study using colon cancer cell line (CaCo-2).", "effective_dosage": "Optimal levels: 30.0 g/l glucose, 5 g/l yeast extract, 10.0 g/l sodium acetate trihydrate.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:05.079584+00:00"}
{"study_id": 21692, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to compare the immune-modulating and anti-tumor effects of Lactobacillus acidophilus (AC2) and other probiotics in a mouse model with CT26 tumors.", "results_summary": "The study found that L. acidophilus (AC2) was less effective than other probiotics (M11, MIX, and 52b) in enhancing Th1 immune responses, cytokine production (IL-12, IFN-\u03b3), and tumor suppression. AC2 did not show significant improvements in lymphocyte proliferation or DTH response compared to the control.", "population_specificity": "Female inbred BALB/c mice bearing CT26 tumors.", "effective_dosage": "1.5 \u00d7 10^8 cfu/ml and 1.2 \u00d7 10^9 cfu/ml, administered orally.", "study_duration": "38 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:05.694728+00:00"}
{"study_id": 21694, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the enteroprotective effect of Lactobacillus acidophilus (LB) and/or umbelliferone (UMB) against methotrexate (MTX)-induced intestinal injury.", "results_summary": "Pretreatment with LB, UMB, or their combination preserved intestinal structure, restored oxidant/antioxidant balance, and suppressed inflammation, with the combination therapy showing superior effects. LB upregulated Wnt and \u03b2-catenin expression and reduced inflammatory markers like TNF-\u03b1 and IL-6.", "population_specificity": "Rats with MTX-induced intestinal injury", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:06.283415+00:00"}
{"study_id": 21693, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine the usefulness of Lactobacillus acidophilus extract (LEX) as a treatment for cedar pollinosis, both alone and in combination with sublingual immunotherapy (SLIT), and its potential as salvage therapy for SLIT non-responders.", "results_summary": "LEX improved quality of life scores and reduced cedar pollen-specific IgE levels from the first year, while SLIT and combination therapy required three years to show efficacy. The combination therapy's efficacy was unclear, but early LEX intake may reduce ineffective cases.", "population_specificity": "Fifteen patients with cedar pollinosis.", "effective_dosage": "Not specified", "study_duration": "Three years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:06.302652+00:00"}
{"study_id": 21695, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the beneficial effects of Lactobacillus acidophilus C4 on DSS-induced colitis in mice, focusing on its ability to alleviate symptoms, repair the mucosal barrier, and maintain intestinal microecological balance.", "results_summary": "L. acidophilus C4 reduced inflammatory cytokines (IL-1\u03b2, IL-6, TNF-\u03b1), increased antioxidant enzymes (SOD, GSH, CAT), elevated tight junction proteins (occludin, ZO-1), reversed microbiota diversity loss, and promoted SCFA levels in DSS-induced colitis mice.", "population_specificity": "DSS-induced colitis mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:07.698606+00:00"}
{"study_id": 21697, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the protective effects of L. acidophilus KLDS1.0901 on high-fat diet-induced NAFLD by examining liver characteristics, gut barrier function, and microbiota modulation.", "results_summary": "L. acidophilus KLDS1.0901 significantly reduced liver lipid accumulation, improved lipid profiles, decreased inflammatory markers, enhanced gut barrier function, and normalized gut microbiota in HFD-fed mice.", "population_specificity": "High-fat diet-induced NAFLD in mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:10.706153+00:00"}
{"study_id": 21696, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine how Lactobacillus acidophilus (LA) affects iron status and blood morphological parameters in healthy female rats, either alone or in combination with isoflavones.", "results_summary": "LA did not significantly affect iron status in healthy female rats, either alone or combined with isoflavones. However, correlations were observed between blood parameters and tissue iron levels, suggesting potential indirect effects.", "population_specificity": "Healthy female Wistar rats aged 3 months.", "effective_dosage": "Not specified (standard diet supplemented with Lactobacillus acidophilus DSM20079).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:10.909048+00:00"}
{"study_id": 21699, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of Lactobacillus acidophilus on anorexigenic peptides and biochemical parameters in rats exposed to a high-fat diet.", "results_summary": "L. acidophilus supplementation reduced triglyceride and total cholesterol levels, lowered leptin levels, and increased GLP-1 and serotonin levels, suggesting positive effects on obesity-related markers.", "population_specificity": "Rats fed a high-fat diet.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:12.028655+00:00"}
{"study_id": 21698, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop and evaluate synbiotic microgels for effectively protecting Lactobacillus acidophilus against external environmental stresses.", "results_summary": "SPI/NaCMC-Al3+8 microgels showed the highest encapsulation efficiency (92%) and probiotic viability after simulated digestion, heat treatment, and refrigerated storage, indicating effective protection of L. acidophilus.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified (concentrations of AlCl3: 0%, 6%, 7%, 8%)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:12.712885+00:00"}
{"study_id": 21700, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of Lactobacillus acidophilus on serum hormones, oxidative stress, and brain receptor levels in hypercholesterolemic rats, comparing it with atorvastatin.", "results_summary": "L. acidophilus administration improved serum cholesterol, insulin, leptin, serotonin, and ghrelin levels, reduced oxidative stress, and increased antioxidant levels in hypercholesterolemic rats, showing comparable benefits to atorvastatin.", "population_specificity": "Hypercholesterolemic rats", "effective_dosage": "2 \u00d7 10^8 cfu/kg/day", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:13.121296+00:00"}
{"study_id": 21701, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-inflammatory role of Lactobacillus acidophilus and its effect on serotonin expression in acetic acid-induced ulcerative colitis in rats.", "results_summary": "The study found that serotonin expression and content significantly increased in colitis-induced rats, and L. acidophilus reduced this abnormal serotonin increase and inflammation in the colon tissue.", "population_specificity": "Adult male rats with acetic acid-induced ulcerative colitis.", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:13.537074+00:00"}
{"study_id": 21702, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lactobacillus acidophilus fermenting Astragalus polysaccharides (APS) was more effective than unfermented APS in improving calcium absorption and osteoporosis.", "results_summary": "The fermentation solution (FS) improved calcium absorption, bone mineral density (BMD), and bone microarchitecture in osteoporotic rats, while also inhibiting osteoclast differentiation markers and pro-inflammatory cytokines and promoting osteoblast differentiation markers. The enhanced effects were linked to gut microbiota restoration and key metabolites.", "population_specificity": "Osteoporotic rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:13.887965+00:00"}
{"study_id": 21703, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the use of Lactobacillus acidophilus in synthesizing cerium oxide nanoparticles for potential therapeutic applications in oxidative damage.", "results_summary": "Lactobacillus acidophilus was used to produce cerium oxide nanoparticles (9-11 nm) with uniform size distribution, which were then loaded with glatiramer acetate (GA) for anti-multiple sclerosis treatment. The GA-loaded nanoparticles demonstrated stable release profiles over 180 minutes, suggesting potential as a drug carrier.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:15.337252+00:00"}
{"study_id": 21705, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of Lactobacillus acidophilus (L28) as a direct-fed microbial in reducing foodborne pathogens in beef cattle.", "results_summary": "Cattle supplemented with Probicon (containing L28) showed significantly reduced prevalence of E. coli O157:H7 and Salmonella in fecal samples, as well as lower C. perfringens concentration, compared to controls and other DFMs.", "population_specificity": "Beef cattle in feedlots.", "effective_dosage": "6 log10CFU/g/head/day.", "study_duration": "5 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:18.400579+00:00"}
{"study_id": 21704, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to determine the effect of Lactobacillus acidophilus on pro-inflammatory cytokine production in peripheral blood mononuclear cells (PBMCs) of endometriosis patients.", "results_summary": "L. acidophilus initially increased pro-inflammatory cytokines (IL-1 and IL-6) in PBMCs of endometriosis patients but showed modulatory effects by reducing these cytokines after 48 hours. The study suggests potential therapeutic benefits for endometriosis.", "population_specificity": "Endometriosis patients (n=11) and non-endometriosis individuals (n=11).", "effective_dosage": "1\u00d710^6 CFU/ml", "study_duration": "48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:18.751932+00:00"}
{"study_id": 21706, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Lactobacillus acidophilus, alone and combined with inulin, on obesity markers (biochemical, anthropometric, and molecular) in an obese murine model.", "results_summary": "The study found that Lactobacillus acidophilus, especially when combined with inulin, improved biochemical markers (glucose, triglycerides, cholesterol) and reduced fat mass index. It also increased the expression of genes related to lipid metabolism and anti-inflammatory cytokines.", "population_specificity": "Obese murine model (mice)", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:19.925299+00:00"}
{"study_id": 21709, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of Lactobacillus acidophilus NCUF202.2 fermentation on Artemisia selengensis Turcz in relieving hyperuricemia and the mechanisms involved.", "results_summary": "Fermented Artemisia selengensis Turcz extracts (FASTE) increased free polyphenol content, enhanced xanthine oxidase inhibition, reduced serum uric acid levels, improved antioxidant activity, and modulated gut microbiota. FASTE outperformed non-fermented extracts in reducing serum adenosine deaminase activity and restoring antioxidant enzymes.", "population_specificity": "Rats with hyperuricemia.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:21.850146+00:00"}
{"study_id": 21708, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lactobacillus acidophilus BIOTECH 1900 affects the transepithelial mucosal-to-serosal transport of colchicine, suggesting possible P-gp induction.", "results_summary": "Lactobacillus acidophilus BIOTECH 1900 significantly reduced colchicine transport and apparent permeability (Papp) in the jejunum of ICR mice, with effects comparable to dexamethasone, a known P-gp inducer. The findings suggest that the probiotic may modulate P-gp activity, potentially altering colchicine absorption.", "population_specificity": "ICR mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Possible interaction with colchicine via P-gp induction", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:21.964533+00:00"}
{"study_id": 21707, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the cardioprotective effects of Lactobacillus acidophilus (LA-5) in combination with Bifidobacterium animalis subsp. lactis (BB-12) on myocardial infarct size in rats with diet-induced obesity and chemically-induced colitis, and its association with gut microbiome and inflammatory markers.", "results_summary": "The combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis reduced myocardial infarct size, lowered pro-inflammatory cytokines (IL-1\u03b2, TNF-\u03b1, IL-2, IL-8), and decreased lipopolysaccharide levels, suggesting improved gut barrier function, though it did not enhance intestinal mucosa healing in chemically-induced colitis.", "population_specificity": "Rats with diet-induced obesity, chemically-induced colitis, and antibiotic-induced dysbiosis.", "effective_dosage": "1.2 \u00d7 10^8 CFU/mL", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:22.317426+00:00"}
{"study_id": 21710, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Lactobacillus acidophilus, alone and combined with organic acids (citric or malic acid), on fermentation parameters and microbial community composition in Chamaecrista rotundifolia silage.", "results_summary": "Lactobacillus acidophilus, especially when combined with organic acids, improved silage quality by inhibiting crude protein degradation, lowering pH and ammonia nitrogen, increasing lactic acid concentration, and enhancing the relative abundance of beneficial bacteria like Lactobacillus while reducing harmful bacteria like Clostridium and Enterobacter. The most effective treatment was 1% organic acid combined with L. acidophilus.", "population_specificity": "Chamaecrista rotundifolia silage (leguminous plant material)", "effective_dosage": "10^6 CFU/g fresh weight of L. acidophilus", "study_duration": "30, 45, and 60 days of ensiling", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:23.085576+00:00"}
{"study_id": 21712, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of combining Lactobacillus acidophilus and its bacteriocin with inulin and FOS on yogurt properties, shelf life, and consumer acceptance.", "results_summary": "The study found that Lactobacillus acidophilus and its bacteriocin, combined with inulin and FOS, extended yogurt shelf life to 39 days, improved sensory properties, and increased beneficial bacterial counts without detecting harmful microorganisms.", "population_specificity": "Yogurt samples (not human subjects).", "effective_dosage": "2% inulin, 2% FOS, and Lactobacillus acidophilus bacteriocin (specific dosage not detailed).", "study_duration": "39 days of refrigerated storage.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:23.674711+00:00"}
{"study_id": 21713, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Lactobacillus acidophilus, alone or combined with moringa leaf extract, on growth performance, immune response, and resistance to Vibrio infections in whiteleg shrimp.", "results_summary": "The study found that Lactobacillus acidophilus combined with 2.5 g/kg moringa extract (ME2.5 + P) significantly improved growth, enzyme activity, gut microbiota, immune response, and survival rates against Vibrio infections compared to controls or moringa alone.", "population_specificity": "Whiteleg shrimp (Penaeus vannamei)", "effective_dosage": "1 \u00d7 10^7 CFU/g of diet", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:26.965987+00:00"}
{"study_id": 21714, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus acidophilus on nucleic acid concentration in extracellular polymeric substances (EPS) derived from root canal bacterial biofilm, comparing it to ethanolic propolis extract.", "results_summary": "The study found that L. acidophilus did not increase nucleic acid concentration in EPS biofilm, but its biosurfactants showed potential for inhibiting biofilm maturation, suggesting promise for endodontic treatment.", "population_specificity": "Clinical bacteria from root canal cultures.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:27.493454+00:00"}
{"study_id": 21715, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Lactobacillus acidophilus (LA) could effectively reduce pain and slow osteoarthritis (OA) progression in a pre-clinical animal model.", "results_summary": "LA significantly reduced inflammatory knee joint pain, prevented OA progression, lowered cartilage-degrading enzymes and pain markers, and altered the fecal microbiota. The findings suggest LA has systemic benefits and potential as a disease-modifying therapy for OA.", "population_specificity": "Mice with OA induced by partial medial meniscectomy (PMM).", "effective_dosage": "Administered by oral gavage twice per week (exact dosage not specified).", "study_duration": "Duration not explicitly stated in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:28.372927+00:00"}
{"study_id": 21716, "supplement_id": 1273, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Lactobacillus acidophilus affects the metabolism of Olsalazine in ulcerative colitis treatment by examining pharmacokinetics, gut microbiota, and metabolic enzymes.", "results_summary": "The study found that L. acidophilus did not alter the pharmacokinetics of Olsalazine or increase colonic exposure to 5-ASA but improved UC treatment by modulating gut microbiota composition and metabolic pathways.", "population_specificity": "Patients with ulcerative colitis (specific details not provided).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:29.763467+00:00"}
{"study_id": 21717, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of diode laser (980 nm) at different times and doses on reducing the growth of Lactobacillus acidophilus.", "results_summary": "The study found that diode laser irradiation significantly reduced L. acidophilus growth, with the most effective dose being 10 J/cm\u00b2 for 5 seconds both immediately and 24 hours after exposure.", "population_specificity": "In vitro bacterial cultures (L. acidophilus at 10\u2078 CFU/ml).", "effective_dosage": "5, 10, and 20 J/cm\u00b2 with irradiation times of 5, 10, and 20 seconds.", "study_duration": "Immediate and 24-hour post-irradiation assessment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:29.983711+00:00"}
{"study_id": 21719, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to sequence the genome of Lactobacillus acidophilus LA-10A to understand its molecular features and its role in treating and preventing Helicobacter pylori infection.", "results_summary": "The study sequenced the genome of Lactobacillus acidophilus LA-10A, providing molecular insights into its characteristics. The strain is noted for its effectiveness in treating and preventing Helicobacter pylori infection.", "population_specificity": "Not specified (strain isolated from fermented mare's milk).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:30.219171+00:00"}
{"study_id": 21718, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the mechanism of action of a combined treatment of Lactobacillus acidophilus and Chinese medicine HKL in alleviating ulcerative colitis by modulating gut microbiota, metabolites, and inflammatory pathways.", "results_summary": "The combined treatment upregulated anti-inflammatory cytokines (IL-13, TGF-\u03b2), downregulated pro-inflammatory markers (TLR9, TLR4), increased beneficial bacteria (Bifidobacterium), reduced opportunistic pathogens (Klebsiella, Escherichia-Shigella), and improved metabolic profiles, including SCFA production.", "population_specificity": "UC rat model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:30.478227+00:00"}
{"study_id": 21720, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus acidophilus NCFM in treating cyclophosphamide-induced hemorrhagic cystitis in Wistar rats.", "results_summary": "Lactobacillus acidophilus NCFM demonstrated a uroprotective effect, preventing bladder inflammation and hemorrhage in both short-term (24-hour) and long-term (30-day) treatments, with results comparable to the standard treatment (mesna).", "population_specificity": "Female Wistar rats with cyclophosphamide-induced hemorrhagic cystitis.", "effective_dosage": "2x10^8 CFU of Lactobacillus acidophilus NCFM.", "study_duration": "24-hour acute treatment and 30-day chronic treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:31.646682+00:00"}
{"study_id": 21721, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lactobacillus acidophilus and other lactobacilli could reduce virulence traits of C. parapsilosis and improve epithelial resistance to fungal infection.", "results_summary": "The study found that Lactobacillus acidophilus cell-free supernatants reduced C. parapsilosis proliferation, viability, and metabolic activity, while also enhancing epithelial resistance to the fungus, suggesting a potential role in preventing mucosal infection.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:34.138716+00:00"}
{"study_id": 21722, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy of Lactobacillus acidophilus in managing acute gastroenteritis in children, focusing on its impact on diarrhea duration and frequency.", "results_summary": "Lactobacillus acidophilus reduced diarrhea duration (moderate-quality evidence) and frequency (significant on day 3), particularly at doses \u2265 10^9 CFU, though the effect was not statistically significant for individual strains alone. No regional differences in efficacy were observed.", "population_specificity": "Children with acute gastroenteritis", "effective_dosage": "\u2265 10^9 CFU daily", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:35.472702+00:00"}
{"study_id": 21723, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anticancer effects of Lactobacillus acidophilus KLDS1.0901 on colon cancer cells, specifically its ability to inhibit proliferation and induce apoptosis.", "results_summary": "L. acidophilus KLDS1.0901 inhibited the proliferation of HT-29 and Caco-2 cells in a dose-dependent manner, increased apoptosis rates and reactive oxygen species in HT-29 cells, and affected mitochondrial membrane potential and gene expression related to apoptosis pathways.", "population_specificity": "Colon cancer cell lines (HT-29, Caco-2) and normal intestinal epithelial cells (IEC-6).", "effective_dosage": "Multiplicity of infection (MOI) = 100 (rate of Lactobacillus to cells).", "study_duration": "48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:37.279080+00:00"}
{"study_id": 21725, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of dietary supplementation with Lactobacillus acidophilus and Bacillus subtilis on intestinal immune response, barrier function, microbiota, and metabolites in late-phase laying hens.", "results_summary": "The study found that supplementation improved intestinal barrier integrity, reduced inflammatory cytokines, increased immunoglobulin levels, enhanced gut microbiota diversity, and positively altered amino acid and lipid metabolism.", "population_specificity": "Late-phase laying hens", "effective_dosage": "250 mg/kg (LD group) and 500 mg/kg (HD group) of a B. subtilis and L. acidophilus mixture powder", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:37.465218+00:00"}
{"study_id": 21726, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to investigate the anti-protozoal effects of Lactobacillus acidophilus LB against Cryptosporidium parvum in comparison to nitazoxanide and other treatments.", "results_summary": "Lactobacillus acidophilus LB showed a high oocysts reduction rate (95.77%), comparable to zinc and dill seed oil, and outperformed clove oil and was slightly better than nitazoxanide (91.55%). Immunohistochemical analysis confirmed the clearance of Cryptosporidium antigen in the intestinal tissue.", "population_specificity": "Mice infected with Cryptosporidium parvum oocysts.", "effective_dosage": "Not specified", "study_duration": "8 consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:38.243919+00:00"}
{"study_id": 21727, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to optimize lactic acid production by Lactobacillus acidophilus PTCC 1643 in a date syrup-based medium using response surface methodology (RSM) and genetic algorithm (GA) analysis.", "results_summary": "The study found that increasing sucrose and yeast extract concentrations enhanced cell growth and lactic acid production, while ultrasound at 25% amplitude significantly stimulated fermentation. However, higher ultrasound amplitude (50%) reduced lactic acid production compared to controls.", "population_specificity": "Not specified (in vitro study).", "effective_dosage": "10-20% sucrose, 1-3% yeast extract, 25-50% ultrasound amplitude.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:38.585025+00:00"}
{"study_id": 21724, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether the combination of Lactobacillus acidophilus and FK506 could effectively and safely mitigate graft-versus-host disease (GvHD) following allogeneic hematopoietic stem cell transplantation.", "results_summary": "The combination treatment suppressed pro-inflammatory T cell differentiation (IFN-\u03b3 and IL-17-producing cells) while enhancing regulatory T cell (Foxp3+Treg) differentiation and IL-10 production. It also alleviated GvHD clinically and histopathologically by modulating the balance between effector T cells and Tregs.", "population_specificity": "Patients undergoing allogeneic hematopoietic stem cell transplantation and liver transplantation patients (peripheral blood mononuclear cells from healthy controls and LT patients were also studied).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Interaction with FK506 (immunosuppressant) was noted, enhancing therapeutic effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:39.397824+00:00"}
{"study_id": 21728, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus acidophilus and/or Mannan oligosaccharides on growth performance, blood biochemical variables, and gut microbiota in crossbred calves.", "results_summary": "Lactobacillus acidophilus improved body weight gain, dry matter digestibility, and blood serum protein levels, while reducing fecal coliform and E. coli counts. The combination with Mannan oligosaccharides (synbiotic) showed similar benefits.", "population_specificity": "Fifteen-day-old crossbred calves (n=24).", "effective_dosage": "2 \u00d7 10^10 cfu/g @ 1 g/calf per day (probiotic), 0.5 g + Mannan oligosaccharide 2 g/calf per day (synbiotic).", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:41.393300+00:00"}
{"study_id": 21731, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anti-obesity effects of Lactobacillus acidophilus isolated from the porcine gut and its potential to improve metabolic health.", "results_summary": "L. acidophilus reduced body weight, fat mass, inflammation, and insulin resistance in mice on a high-fat diet, improved gut microbiota composition, and enhanced metabolic functions. The anti-obesity effects were transmissible via fecal transfer.", "population_specificity": "Mice fed a high-fat diet (HFD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:44.407865+00:00"}
{"study_id": 21732, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess whether Lactobacillus acidophilus and Lactobacillus rhamnosus could reduce H. pylori bacterial load and modify gut microbiota.", "results_summary": "The probiotic group showed a significant reduction in H. pylori bacterial load compared to placebo, but no eradication of H. pylori or significant changes in gut microbiota composition were observed.", "population_specificity": "40 adult subjects with moderate to high H. pylori bacterial loads.", "effective_dosage": "Probiotics containing Lactobacillus acidophilus and Lactobacillus rhamnosus, twice daily (specific strain counts not provided).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:45.223336+00:00"}
{"study_id": 21729, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of nonviable Lactobacillus acidophilus (NVL) and a mixed prebiotic blend on fecal microbiota, fermentative end products, and gut immune health in dogs.", "results_summary": "The study found that the mixed prebiotic (MP) blend, with or without NVL, significantly altered fecal microbiota, reduced fecal pH, increased fecal IgA, and improved fermentative end products. NVL alone showed fewer effects, but the combination with MP enhanced some benefits, such as reducing harmful fecal compounds.", "population_specificity": "Healthy adult Beagle dogs (n = 24; 5.74 \u00b1 2.18 years; 9.30 \u00b1 1.32 kg).", "effective_dosage": "Not specified (fed once daily to maintain body weight).", "study_duration": "21 days per treatment period (total of four treatment and four washout periods).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:45.297303+00:00"}
{"study_id": 21730, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining Lactobacillus acidophilus (LA) with tacrolimus (Tac) improves therapeutic efficacy by modulating T cell subsets in a murine model of systemic lupus erythematosus (SLE).", "results_summary": "The combination therapy of LA and Tac restored gut dysbiosis, reduced double-negative T cells, lowered serum autoantibodies, alleviated renal pathology, and improved Th17/Treg balance in SLE mice. LA also induced immune-modulating molecules like IDO, PD-L1, and IL-10 in vitro.", "population_specificity": "MRL/lpr mice (a murine model of SLE).", "effective_dosage": "50 mg/kg of LA daily.", "study_duration": "8 weeks.", "interactions": "Tacrolimus (Tac).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:45.766049+00:00"}
{"study_id": 21734, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to determine whether Lactobacillus acidophilus could stimulate and modulate the respiratory immune system in response to SARS-CoV-2-related immune challenges.", "results_summary": "The study found that Lactobacillus acidophilus treatment resulted in higher lymphocyte counts and significant differences in lymphocyte infiltration in lung tissue compared to controls, suggesting immune modulation.", "population_specificity": "Male DDY strain mice (Mus musculus) aged 1-2 months.", "effective_dosage": "1 \u00d7 10^8 CFU/ml dissolved in 0.25 ml 0.9% NaCl.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:46.634906+00:00"}
{"study_id": 21733, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the supportive therapy potential of acidophilus milk (containing Lactobacillus acidophilus LA-5) and propolis extract in a mouse xenograft breast cancer model.", "results_summary": "The combination of acidophilus milk and propolis extract significantly inhibited tumor volumes by 63.39%, enhanced splenocyte proliferation, and stimulated IFN-\u03b3 production. The study concluded that the combination showed the best anti-tumor effect.", "population_specificity": "Balb/c mice injected with 4T1 mouse breast cancer cells.", "effective_dosage": "108 CFU/mL/mouse/day of acidophilus milk.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:46.896314+00:00"}
{"study_id": 21735, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combining Lactobacillus acidophilus with Clostridium cochlearium (CC-LA) could reduce obesity and improve glucose metabolism in high-fat diet-induced obese mice.", "results_summary": "The CC-LA group showed 17% less body weight gain, improved glucose tolerance, reduced insulin resistance, and favorable changes in gut microbiota diversity compared to the high-fat diet control group. The Firmicutes to Bacteroidetes ratio decreased significantly, and obesity-related microbial taxa were reduced.", "population_specificity": "6-week-old male C57BL/6 mice fed a high-fat diet.", "effective_dosage": "Not specified (CC-LA mixture administered, exact dosage not detailed).", "study_duration": "17 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:48.292247+00:00"}
{"study_id": 192670, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine whether probiotic supplementation (Lactobacillus acidophilus) enhanced the effects of caloric restriction on body composition, quality of life, sleep quality, and mental health symptoms in obese adult men.", "results_summary": "Probiotic supplementation did not improve body composition, quality of life, or sleep parameters compared to caloric restriction alone. However, it was associated with reduced anxiety and depressive symptoms in the probiotic group, though no significant differences were found between groups after 12 weeks.", "population_specificity": "Adult men aged 25-44 with obesity (BMI 30.0-39.99 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:49.949200+00:00"}
{"study_id": 192672, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine the effect of a commercially available multi-ingredient powder (AG1) containing Lactobacillus acidophilus on human health.", "results_summary": "The abstract does not provide specific results regarding Lactobacillus acidophilus's effects.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:50.646807+00:00"}
{"study_id": 192680, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether probiotics, including Lactobacillus acidophilus, reduce in-hospital mortality and improve cardiovascular outcomes in patients with acute myocardial infarction.", "results_summary": "The abstract does not provide results, as the study appears to be ongoing or not yet concluded.", "population_specificity": "Adult patients diagnosed with acute myocardial infarction (n=2594).", "effective_dosage": "840 mg (Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis) twice daily.", "study_duration": "Up to 30 days during hospital stay.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:54.107585+00:00"}
{"study_id": 192679, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether probiotic supplementation, including Lactobacillus acidophilus, could improve gut microbiota composition in cesarean-delivered infants.", "results_summary": "Probiotic supplementation increased beneficial bacteria abundance and reduced colonization of potentially pathogenic Klebsiella in cesarean-delivered infants. The intervention enriched gut microbiota composition and altered early colonization patterns.", "population_specificity": "Full-term neonates delivered by cesarean section.", "effective_dosage": "Not specified (probiotic contained Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:54.198295+00:00"}
{"study_id": 192676, "supplement_id": 1273, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether probiotics, including Lactobacillus acidophilus, could alleviate gastrointestinal symptoms (GIS) and influence Small Intestine Bacterial Overgrowth (SIBO) in patients one year after Roux-en-Y Gastric Bypass (RYGB).", "results_summary": "The study found no significant effects of probiotic supplementation on gastrointestinal symptoms or SIBO prevalence in post-RYGB patients. The chosen probiotic blend, including Lactobacillus acidophilus, did not alleviate symptoms or improve SIBO.", "population_specificity": "Symptomatic patients one year after Roux-en-Y Gastric Bypass (RYGB).", "effective_dosage": "50 billion CFU (combined with other probiotic strains) daily for 8 weeks.", "study_duration": "8 weeks per intervention period, with an 8-week washout between periods.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:54.768079+00:00"}
{"study_id": 192681, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of probiotic supplementation on hepatic fibrosis, inflammatory and metabolic markers, and gut microbiota in patients with nonalcoholic steatohepatitis (NASH).", "results_summary": "The study found that probiotic supplementation improved the AST to Platelet Ratio Index (APRI) score but did not significantly affect liver fibrosis, steatosis, inflammatory activity, or gut microbiota composition. The results suggest probiotics alone may not be sufficient to improve enzymatic liver markers or inflammatory parameters in NASH patients.", "population_specificity": "48 patients with NASH, median age 58 y, median BMI 32.7 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:56.034587+00:00"}
{"study_id": 192682, "supplement_id": 1273, "safety_score": "80", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a 24-week probiotic mix containing Lactobacillus acidophilus could reduce cardiovascular risk markers in patients with non-alcoholic steatohepatitis (NASH).", "results_summary": "The study found no significant difference between the probiotic and placebo groups in reducing cardiovascular risk markers, including atherogenic indexes, PAI-1, and miR-122 levels. Probiotic supplementation did not outperform placebo in improving clinical or laboratory parameters.", "population_specificity": "Adult patients with biopsy-proven non-alcoholic steatohepatitis (NASH), predominantly female and white.", "effective_dosage": "10^10 CFU daily (probiotic mix, exact Lactobacillus acidophilus dosage not specified).", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:57.482250+00:00"}
{"study_id": 192683, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of probiotic (Lactobacillus acidophilus) and fluconazole on the treatment and recurrence of vulvovaginal candidiasis (VVC).", "results_summary": "The study compared probiotic capsules with fluconazole for treating VVC, but the abstract does not specify the exact outcomes for Lactobacillus acidophilus.", "population_specificity": "80 married women aged 18-49 years with confirmed VVC.", "effective_dosage": "30 probiotic capsules containing 1 \u00d7 10^[CFU/dose not fully specified].", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:58.103205+00:00"}
{"study_id": 192684, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate whether a supplement containing tyndallized Lactobacillus acidophilus (HA122) could improve inflammatory markers (IL-6, CRP) and modulate lymphocyte growth in elderly patients.", "results_summary": "The study found that the supplement improved IL-6, CRP, and lymphocyte levels in elderly patients after 30 days of use, though they did not reach the same levels as young patients. Over 70% of patients reported feeling better after supplementation.", "population_specificity": "Elderly patients over 60 years old, compared to a young control group.", "effective_dosage": "Not specified (result was independent of dosage).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:59.061476+00:00"}
{"study_id": 192685, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to assess whether probiotic supplementation, including Lactobacillus acidophilus, could improve athletic performance in resistance and aerobic exercises.", "results_summary": "Two studies using Lactobacillus acidophilus observed positive results on performance, but most studies (11 out of 17) showed no effect of probiotics on aerobic performance or muscular strength. The overall evidence was insufficient to support performance improvement.", "population_specificity": "Athletes, recreationally trained individuals, and untrained healthy individuals aged 18 to 40 years (73% male).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:02.531631+00:00"}
{"study_id": 192687, "supplement_id": 1273, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of a multi-strain probiotic, including Lactobacillus acidophilus, combined with dietary and lifestyle modifications, on menstrual regularity, metabolic and hormonal profiles in women with PCOS.", "results_summary": "The probiotic supplement significantly improved menstrual cycle regularity, total testosterone levels, waist circumference, waist-to-hip ratio, and quality of life in women with PCOS compared to placebo. No adverse events were reported.", "population_specificity": "Women aged 18-40 years with polycystic ovary syndrome (PCOS).", "effective_dosage": "Lactobacillus acidophilus UBLA-34 (2 billion CFU per strain, along with other probiotic strains and fructo-oligosaccharides (100 mg)).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:03.440552+00:00"}
{"study_id": 192686, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of synbiotics (including Lactobacillus acidophilus) on indoxyl sulphate levels, constipation symptoms, and constipation-related quality of life in haemodialysis patients.", "results_summary": "The study found no significant reduction in indoxyl sulphate levels but observed improvements in constipation symptoms and constipation-related quality of life after synbiotic administration.", "population_specificity": "Chronic haemodialysis patients with gastrointestinal complaints, difficulty defecating, hard stool consistency, or fewer than three bowel movements per week.", "effective_dosage": "Lactobacillus acidophilus and Bifidobacterium longum at 5x10^9 CFU (exact frequency not specified).", "study_duration": "Two months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:03.602294+00:00"}
{"study_id": 192688, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of probiotic supplementation, particularly Lactobacillus acidophilus, in improving liver function, lipid parameters, and anthropometric characteristics in pediatric patients with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "The meta-analysis found that probiotic supplementation, including Lactobacillus acidophilus combined with other strains, significantly improved transaminase levels, lipid profiles, ultrasonographic steatosis, and anthropometric measures in children with NAFLD. The effects were statistically significant and clinically relevant.", "population_specificity": "Pediatric patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:04.211697+00:00"}
{"study_id": 192692, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the impact of a probiotic supplement containing Lactobacillus acidophilus on the incidence and duration of upper respiratory tract infection symptoms in healthy children.", "results_summary": "The abstract does not provide specific results regarding the effects of Lactobacillus acidophilus.", "population_specificity": "Healthy school children aged 3-10 years.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:05.484276+00:00"}
{"study_id": 192689, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Lactobacillus acidophilus supplementation could improve neurologic function in mild traumatic brain injury (mTBI) by alleviating gut microbiome dysbiosis.", "results_summary": "In animal models, Lactobacillus acidophilus supplementation improved neurologic function following TBI, but no human studies confirmed neurologic benefits, though it reduced infection rates in severe TBI patients.", "population_specificity": "Animal models (TBI) and human patients (severe TBI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:05.731110+00:00"}
{"study_id": 192691, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to assess the prevalence of necrotising enterocolitis (NEC) in very-low-birth-weight newborns after supplementation with the probiotic Inforan.", "results_summary": "The study found that probiotic supplementation reduced the incidence of NEC, though it did not compare the efficacy of different probiotic strains.", "population_specificity": "Very-low-birth-weight (VLBW) newborns (n=245).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:06.370695+00:00"}
{"study_id": 192693, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of probiotic supplementation with Lactobacillus acidophilus on cognitive functioning, focusing on its potential role in influencing inflammation and immune response.", "results_summary": "The abstract suggests that probiotics, including Lactobacillus acidophilus, may have beneficial effects on cognitive functioning, potentially mediated by their impact on inflammation and immune response, though human data remain limited.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:10.423620+00:00"}
{"study_id": 192694, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lactobacillus acidophilus, when used with or after antibiotics, could help restore gut microbiota in neonates with infections.", "results_summary": "Probiotics (including Lactobacillus acidophilus) used concurrently with antibiotics showed some benefit in promoting Bifidobacterium abundance but did not restore overall gut microbiota diversity. Early probiotic use appeared more beneficial than delayed use.", "population_specificity": "Full-term neonates diagnosed with neonatal infections.", "effective_dosage": "Not specified", "study_duration": "1 week (concurrent or post-antibiotic use)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:10.714289+00:00"}
{"study_id": 192699, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether a probiotic combination including Lactobacillus acidophilus could reduce upper respiratory infection frequency and severity in children by modulating inflammatory immune responses.", "results_summary": "The abstract suggests that probiotic supplementation may decrease upper respiratory infection frequency and severity in children, potentially through immune modulation, but specific results for Lactobacillus acidophilus are not detailed.", "population_specificity": "Children", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:12.299090+00:00"}
{"study_id": 192696, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of a probiotic mixture containing Lactobacillus acidophilus on inflammatory biomarkers, oxidative/nitrosative stress, and disease activity in people with rheumatoid arthritis.", "results_summary": "The probiotic group showed significant reductions in white blood cell count, tumor necrosis factor-\u03b1, and interleukin-6 levels, as well as improvements in oxidative/nitrosative stress biomarkers, though no changes were observed in other inflammatory markers or disease activity scores.", "population_specificity": "42 participants with rheumatoid arthritis", "effective_dosage": "10^9 CFU/g daily (as part of a multi-strain probiotic mixture)", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:12.557366+00:00"}
{"study_id": 192695, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether probiotic supplementation with Lactobacillus acidophilus during pregnancy reduces the risk of gestational diabetes mellitus (GDM) and improves maternal and neonatal outcomes.", "results_summary": "The study found that probiotic supplementation from the second trimester up to 24 weeks of pregnancy did not reduce the risk of GDM or improve other maternal and neonatal outcomes.", "population_specificity": "Pregnant women in the Middle East, with a mean age of 32.03 years and BMI of 30.20 kg/m\u00b2.", "effective_dosage": "500 mg probiotic capsule (containing Lactobacillus acidophilus LA1 >7.5 \u00d7 10^7 CFU) daily.", "study_duration": "From 14 weeks of pregnancy up to 24 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:12.683232+00:00"}
{"study_id": 192674, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to assess the influence of probiotic supplementation (Lactobacillus acidophilus) on monocyte functionality in marathon runners before and after the race.", "results_summary": "The abstract does not provide specific results regarding Lactobacillus acidophilus's effects, only mentioning the study's intent to evaluate its impact on immune response in runners.", "population_specificity": "Marathon runners undergoing intense training and prolonged exercise.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:13.593933+00:00"}
{"study_id": 192700, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether 30 days of probiotic supplementation could stabilize the immune system of marathon runners and prevent immune suppression post-race.", "results_summary": "The abstract does not provide specific results regarding Lactobacillus acidophilus, as the study used Bifidobacterium animalis subsp. lactis.", "population_specificity": "27 male marathon runners", "effective_dosage": "10 \u00d7 10 CFU (specific frequency not mentioned)", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:14.241248+00:00"}
{"study_id": 192698, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether probiotic supplementation, including Lactobacillus acidophilus, could moderate the immune system's response to sleep disruption caused by night shift work.", "results_summary": "Probiotic supplementation moderated changes in serum markers (cortisol, pentraxin, MAdCAM-1, IL-1ra) associated with anticipatory stress before night shifts, though no significant interaction effects were observed post-shift. The placebo group showed significant changes in these markers during the normal sleep period.", "population_specificity": "Night shift workers (mean age 41 \u00b1 11 yrs; 74% female).", "effective_dosage": "1 \u00d7 10^10 CFU/day (specific strain details not fully provided).", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:16.045421+00:00"}
{"study_id": 192701, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether probiotic supplementation, including Lactobacillus acidophilus LA02, aids weight loss in healthy young adult females and to test manufacturers' claims.", "results_summary": "The study found no significant changes in anthropometric measures (body mass, BMI, body fat percentage, etc.) in either the probiotic or placebo groups, suggesting Lactobacillus acidophilus LA02 did not aid weight loss under the tested conditions.", "population_specificity": "Healthy young adult females aged 19-33.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:18.125405+00:00"}
{"study_id": 192706, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the prophylactic probiotic use of Lactobacillus acidophilus in infants within the German Neonatal Network.", "results_summary": "The abstract is incomplete, but it mentions that 76.5% of infants received the probiotic, though no specific outcomes or effects are detailed.", "population_specificity": "Infants in the German Neonatal Network.", "effective_dosage": "Not available", "study_duration": "Six years (observational period from 2013 to 2018).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:19.938357+00:00"}
{"study_id": 192703, "supplement_id": 1273, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of probiotic therapy, including Lactobacillus acidophilus NCFM, on cardiometabolic variables and autonomic function in women with arterial hypertension.", "results_summary": "Probiotic supplementation significantly reduced fasting glucose and cholesterol levels, increased HDL-cholesterol, and improved autonomic modulation, though blood pressure reductions were not statistically significant.", "population_specificity": "Women aged 20-50 years medically diagnosed with arterial hypertension.", "effective_dosage": "10^9 CFU daily (combined with other probiotic strains).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:20.392972+00:00"}
{"study_id": 192702, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of Lactobacillus acidophilus and Bifidobacterium lactis supplementation on gastrointestinal symptoms and small intestine bacterial overgrowth (SIBO) in patients after Roux-en-Y gastric bypass (RYGB).", "results_summary": "The probiotic supplementation reduced bloating but did not influence SIBO development. It also led to mixed effects, including more abdominal pain at T1 (which later reduced), more soft stools and nausea, and less hunger pain, with no urgent episodes to evacuate despite higher fat consumption.", "population_specificity": "Patients who underwent Roux-en-Y gastric bypass (RYGB).", "effective_dosage": "5 billion CFU/strain (Lactobacillus acidophilus and Bifidobacterium lactis) daily.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:20.558560+00:00"}
{"study_id": 192705, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of a synbiotic containing Lactobacillus acidophilus NCFM on systemic inflammation and gut functioning in community-dwelling elders.", "results_summary": "The study found no significant changes in inflammatory markers but observed subtle improvements in gut functioning and stool types in the synbiotic group. The benefits were less pronounced compared to studies involving individuals with diagnosed dysbiosis.", "population_specificity": "Community-dwelling elders (n=49, aged not specified).", "effective_dosage": "Lactobacillus acidophilus NCFM at 10^9 to 10^8 UFC (colony-forming units) daily, combined with other probiotics and prebiotics.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:21.305947+00:00"}
{"study_id": 192708, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of probiotics, including Lactobacillus acidophilus, on glycaemic control in adults with type 2 diabetes mellitus (T2DM).", "results_summary": "The review found that multistrain probiotics containing Lactobacillus acidophilus, administered for 6 to 12 weeks, may improve glycaemic control in adults with T2DM, based on outcomes like fasting plasma glucose and insulin resistance. Further research is needed to optimize dosing and duration.", "population_specificity": "Adults with type 2 diabetes mellitus (T2DM).", "effective_dosage": "7 million to 100 billion colony forming units (CFU).", "study_duration": "6 to 12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:22.796852+00:00"}
{"study_id": 192709, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of probiotic (containing Lactobacillus acidophilus) and synbiotic supplementation on depression and anxiety symptoms and serum BDNF levels in HD patients.", "results_summary": "Synbiotic supplementation significantly reduced depression symptoms (HADS-DEP score) and improved serum BDNF levels compared to probiotic supplementation alone, particularly in patients with depressive symptoms.", "population_specificity": "Seventy-five hemodialysis (HD) patients.", "effective_dosage": "5 g of probiotic (containing Lactobacillus acidophilus) daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:24.161695+00:00"}
{"study_id": 192711, "supplement_id": 1273, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of probiotic supplementation, including Lactobacillus acidophilus, on gastrointestinal symptoms and immune response markers in marathon runners.", "results_summary": "Probiotic supplementation reduced the prevalence and severity of GI symptoms during the marathon, particularly in the latter stages, and was associated with a smaller reduction in running speed compared to placebo. However, no significant differences were found in circulatory markers between groups.", "population_specificity": "Recreational marathon runners", "effective_dosage": "25 billion CFU (combined with other probiotic strains)", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:27.388654+00:00"}
{"study_id": 192710, "supplement_id": 1273, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of probiotic yoghurts containing Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 on maternal plasma glucose levels and maternal/infant complications in overweight and obese pregnant women without diabetes.", "results_summary": "The study found that probiotic yoghurt significantly lowered fasting plasma glucose and 2-h OGTT levels compared to conventional yoghurt, with no significant differences in gestational diabetes risk or preterm delivery. Infant bilirubin levels were also significantly lower in the probiotic group.", "population_specificity": "Overweight and obese pregnant women (BMI \u2265 25) with no diabetes and fasting plasma glucose < 92 mg/dl at 22 weeks of gestation.", "effective_dosage": "100 g/day of probiotic yoghurt", "study_duration": "From 24 weeks of gestation until delivery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:27.444690+00:00"}
{"study_id": 192714, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of synbiotic and probiotic supplementation, including Lactobacillus acidophilus, on serum vascular dysfunction and necrosis markers in hemodialysis patients.", "results_summary": "The study found that supplementation with synbiotics or probiotics, including Lactobacillus acidophilus, had a measurable effect on serum markers in hemodialysis patients, though specific results for Lactobacillus acidophilus alone are not detailed in the abstract.", "population_specificity": "Hemodialysis patients", "effective_dosage": "5 g probiotic powder containing Lactobacillus acidophilus strain T16 (IBRC-M10785)", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:29.242567+00:00"}
{"study_id": 192713, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of probiotic and synbiotic supplementation, including Lactobacillus acidophilus, on serum inflammatory markers, endotoxin, and anti-HSP70 in hemodialysis patients.", "results_summary": "The study found that synbiotic supplementation, which included Lactobacillus acidophilus, had measurable effects on serum inflammatory markers and endotoxin levels in hemodialysis patients, though specific results for Lactobacillus acidophilus alone were not detailed in the abstract.", "population_specificity": "Hemodialysis patients meeting specific inclusion and exclusion criteria.", "effective_dosage": "5 g of probiotic powder containing Lactobacillus acidophilus T16 (among other strains), administered daily.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:29.674281+00:00"}
{"study_id": 192715, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of a probiotic supplement containing Lactobacillus acidophilus LA-5 on inflammation and oxidative stress biomarkers in pregnant women with gestational diabetes mellitus (GDM).", "results_summary": "The probiotic supplement significantly improved serum high-sensitivity C-reactive protein, tumor necrosis factor-\u03b1, malondialdehyde, glutathione reductase, and erythrocyte glutathione peroxidase levels compared to placebo. Interleukin-6 levels decreased in both groups but without statistical significance.", "population_specificity": "Pregnant women with newly-diagnosed GDM (n=64).", "effective_dosage": "Not specified (capsule containing four bacterial strains, including L. acidophilus LA-5).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:31.589475+00:00"}
{"study_id": 192707, "supplement_id": 1273, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if oral intake of a Lactobacillus mixture (including L. acidophilus) could reduce recurrence rates of bacterial vaginosis in recently treated women.", "results_summary": "The study found that the Lactobacillus mixture significantly reduced BV recurrence (18.3% in the verum group vs. 32.1% in placebo, p = .014) and prolonged time to recurrence. Both supplements were well tolerated.", "population_specificity": "Women aged 18-45 with recently cured symptomatic BV, treated with metronidazole.", "effective_dosage": "1 capsule (5.4 billion CFU total, with L. acidophilus comprising 20%) twice daily for 7 days, then once daily for 8-120 days.", "study_duration": "Up to 120 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:33.767138+00:00"}
{"study_id": 192716, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether a probiotic containing Lactobacillus acidophilus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 could prevent radiation-induced diarrhea in cervical cancer patients undergoing radiotherapy.", "results_summary": "The probiotic significantly reduced the incidence and severity of diarrhea, decreased the need for anti-diarrheal medication, and reduced abdominal pain compared to the placebo group.", "population_specificity": "Cervical cancer patients receiving external beam pelvic radiotherapy with or without concurrent chemotherapy.", "effective_dosage": "1.75 billion lyophilized live bacteria per capsule, taken three times daily.", "study_duration": "From the first day of radiotherapy until the end of radiotherapy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:35.707131+00:00"}
{"study_id": 192718, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of probiotic supplementation (including Lactobacillus acidophilus) on gut microbiota and inflammatory markers in chronic kidney disease patients undergoing hemodialysis.", "results_summary": "The study found that probiotic supplementation did not reduce uremic toxins or inflammatory markers in hemodialysis patients, suggesting limited efficacy in this population.", "population_specificity": "Chronic kidney disease patients undergoing maintenance hemodialysis (n=46, with 23 in the probiotic group).", "effective_dosage": "90 billion colony-forming units per day (combined with Streptococcus thermophilus and Bifidobacterium longum).", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:35.745285+00:00"}
{"study_id": 192717, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of probiotic supplementation (including Lactobacillus acidophilus) combined with circuit training on muscular strength, power, and cytokine responses in young males.", "results_summary": "The study compared probiotic supplementation with and without circuit training but did not explicitly report the specific outcomes for Lactobacillus acidophilus alone. The abstract suggests an investigation into combined effects rather than isolated probiotic efficacy.", "population_specificity": "Healthy sedentary young males (n=48).", "effective_dosage": "Multi-strain probiotics containing 3 \u00d7 10^? CFU (exact dosage incomplete in abstract).", "study_duration": "12 weeks (8 weeks with 2 circuits, 9-12 weeks with 3 circuits).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:37.572146+00:00"}
{"study_id": 192720, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if routine probiotic supplementation with Lactobacillus acidophilus + Lactobacillus bifidum reduces the risk of necrotising enterocolitis (NEC)\u2265Stage II, late-onset sepsis, and mortality in preterm neonates born at \u226432 weeks' gestation.", "results_summary": "The study found a significant reduction in NEC\u2265Stage II (11.3% vs. 4.8%), late-onset sepsis (16% vs. 10.5%), and mortality (19.4% vs. 2.3%) in neonates \u226432 weeks after probiotic supplementation. Benefits in neonates \u226427 weeks were not statistically significant.", "population_specificity": "Preterm neonates born at \u226432 weeks' gestation with very low birth weight.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:38.292967+00:00"}
{"study_id": 192721, "supplement_id": 1273, "safety_score": "80", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a probiotic formulation containing Lactobacillus acidophilus could reduce the time to reach full enteral feeds in very low birth weight newborns.", "results_summary": "The study found no significant difference in the time to reach full enteral feeds between the probiotic and control groups, though there was a trend toward lower necrotizing enterocolitis rates in the probiotic group.", "population_specificity": "Very low birth weight newborns (750-1499 g) in a tertiary care NICU in Southern India.", "effective_dosage": "1.25\u00d710^9 CFU once daily (multicomponent probiotic formulation).", "study_duration": "From initiation of enteral feeds until discharge.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:38.640571+00:00"}
{"study_id": 192712, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of probiotic (including Lactobacillus acidophilus) and selenium co-supplementation on cognitive function and metabolic status in Alzheimer's disease patients.", "results_summary": "Probiotic and selenium co-supplementation significantly improved cognitive function, reduced inflammation and oxidative stress markers, and enhanced metabolic profiles compared to placebo or selenium alone.", "population_specificity": "79 patients with Alzheimer's disease.", "effective_dosage": "Probiotic containing Lactobacillus acidophilus, Bifidobacterium bifidum, and Bifidobacterium longum (2 \u00d7 10^9 CFU/day) plus selenium (200 \u03bcg/day).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:39.507121+00:00"}
{"study_id": 192722, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether maternal probiotic supplementation with Lactobacillus acidophilus (La-5) and other strains could reduce atopic dermatitis (AD) in offspring by modulating Th cell proportions.", "results_summary": "Maternal probiotic supplementation reduced Th22 cell proportions in children, which partially mediated the preventive effect on AD. Children who developed AD had higher Th22 cell proportions compared to those who did not.", "population_specificity": "Pregnant women and their offspring (assessed at 3 months and followed for 2 years).", "effective_dosage": "Combination of Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. lactis Bb-12, and Lactobacillus acidophilus La-5 (specific dosage not mentioned).", "study_duration": "Perinatal supplementation (duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:40.876454+00:00"}
{"study_id": 192723, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a probiotic mix containing Lactobacillus acidophilus, when combined with dietary intervention, was more effective than dietary intervention alone in improving body composition, lipid profile, endotoxemia, inflammation, and antioxidant activity in women with excess weight or obesity.", "results_summary": "The probiotic mix group showed significantly greater reductions in waist circumference, waist-height ratio, conicity index, and plasma polyunsaturated fatty acids, along with increased glutathione peroxidase activity compared to the dietary intervention alone group.", "population_specificity": "Women with excess weight or obesity", "effective_dosage": "2 \u00d7 10^? CFU (exact dosage unclear from abstract)", "study_duration": "Not specified in abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:42.597736+00:00"}
{"study_id": 192725, "supplement_id": 1273, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the optimal duration of a synbiotic containing Lactobacillus acidophilus for controlling respiratory infections and wheezing in young children.", "results_summary": "The synbiotic reduced the incidence of respiratory infections and wheezing, with significant increases in tIgA serum levels after three months and lower total IgE serum levels after nine months. The effects were most pronounced in children with recurrent respiratory infections and wheezing.", "population_specificity": "Children younger than five years with a history of hospitalization.", "effective_dosage": "5 x 10\u2079 CFU (Lactobacillus acidophilus Rosell-52, Bifidobacterium infantis Rosell-33, Bifidobacterium bifidum Rosell-71).", "study_duration": "Up to nine months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:44.548441+00:00"}
{"study_id": 192724, "supplement_id": 1273, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether probiotic supplementation with Lactobacillus acidophilus could reduce exercise-induced tryptophan degradation and the incidence of upper respiratory tract infections (URTI) in trained athletes.", "results_summary": "The study found that probiotic supplementation limited exercise-induced drops in tryptophan levels and reduced the incidence of URTI, though it did not improve athletic performance.", "population_specificity": "Thirty-three highly trained athletes during winter training.", "effective_dosage": "2 \u00d7 10^10 CFU/day (Lactobacillus acidophilus CUL-60 and CUL-21, Bifidobacterium bifidum CUL-20, and Bifidobacterium animalis subsp. lactis CUL-34).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:44.867384+00:00"}
